virusbas
nanomateri
versatil
materi
natur
selfassembl
relev
broad
rang
applic
includ
medicin
biotechnolog
energi
review
provid
overview
recent
develop
chemic
virolog
virus
materi
provid
uniqu
nanoscal
scaffold
relev
chemic
biolog
nanotechnolog
divers
area
applic
fundament
advantag
virus
compar
synthet
program
materi
includ
highli
precis
spatial
arrang
subunit
divers
array
shape
size
mani
avail
avenu
easi
reproduc
modif
first
survey
broad
distribut
virus
variou
method
produc
virusbas
nanoparticl
well
engin
principl
use
impart
new
function
examin
broad
rang
applic
implic
virusbas
materi
focus
medic
biotechnolog
energi
sector
anticip
field
continu
evolv
grow
excit
new
possibl
stem
advanc
ration
design
virusbas
nanomateri
nanosci
date
feasibl
synthet
creat
nanoparticl
compar
reproduc
beauti
util
collabor
effort
research
physic
chemic
virolog
direct
toward
unravel
process
selfassembl
genom
packag
understand
control
selfassembl
virusbas
materi
higherord
hierarch
structur
engin
studi
virusbas
viruslik
materi
applic
health
energi
sector
scaledup
manufactur
materi
applic
clinic
devic
review
provid
gener
synopsi
engin
virusbas
viruslik
materi
discuss
manifold
divers
applic
start
introduc
use
virus
materi
perspect
consid
method
produc
modifi
particl
survey
recent
develop
expans
applic
discuss
focus
util
virusbas
materi
medicin
deliveri
system
contrast
agent
biotechnolog
nanoreactor
sens
devic
energi
batteri
electrod
storag
devic
final
assess
opportun
challeng
clinic
commerci
applic
virusinspir
materi
nanoscal
engin
revolution
divers
disciplin
scienc
engin
use
viral
scaffold
particular
led
advanc
scientif
knowledg
selfassembl
develop
novel
materi
widerang
applic
virus
studi
year
type
virus
discov
describ
come
varieti
shape
size
chemist
point
view
harbor
mani
natur
featur
uniqu
relev
nanotechnolog
crystal
structur
manner
virus
simpli
use
wellord
materi
separ
normal
role
infect
virus
made
coat
protein
subunit
natur
selfassembl
truli
monodispers
particl
understand
coat
protein
build
block
chemic
biolog
ever
increas
complex
assembl
program
includ
nanoboomerangand
tetrapodshap
viru
materi
largescal
product
virus
easili
achiev
propag
natur
host
express
heterolog
system
see
section
addit
particl
come
varieti
shape
size
function
nanoscaffold
easili
reproduc
modifi
shown
figur
common
architectur
icosahedron
filament
phage
headandtail
structur
divers
structur
spindl
zipper
bottleshap
virus
also
exist
biotechnolog
arm
seek
engin
particl
applic
medicin
energi
also
basic
arm
investig
viru
assembl
structur
two
arm
research
interconnect
crosstalk
two
field
provid
insight
advanc
exampl
studi
physic
pack
signal
rna
virus
led
applic
encapsul
therapeut
nanomed
applic
see
section
addit
fundament
understand
interact
involv
particl
selfassembl
inform
fabric
novel
imag
agent
see
section
multidisciplinari
collabor
use
viral
scaffold
uniqu
materi
divers
applic
realiz
differenti
virus
contain
nativ
nucleic
acid
refer
viral
nanoparticl
vnp
virus
devoid
nucleic
acid
consid
viruslik
particl
vlp
classif
virus
base
number
featur
includ
shape
structur
capsid
shown
figur
type
nucleic
acid
contain
doublestrand
ds
singlestrand
ss
rna
dna
host
speci
classic
virolog
taxonomi
util
baltimor
classif
virus
virus
group
accord
genom
well
method
replic
figur
illustr
seven
differ
classif
virus
demonstr
evolv
mani
differ
strategi
replic
howev
part
consid
plant
virus
bacteriophag
noninfecti
particl
use
materi
make
nativ
cargo
capsid
less
relev
mammalian
virus
adenoviru
class
dsdna
viru
adenoassoci
viru
aav
class
ii
ssdna
viru
offer
mani
advantag
applic
gene
therapi
administ
make
modif
genet
sequenc
therapeut
prophylact
purpos
see
section
also
present
opportun
cancer
immunotherapi
seen
recent
approv
tvec
treatment
melanoma
see
section
nevertheless
bacteriophageand
plant
virusderiv
materi
may
offer
advantag
manufactur
scalabl
ferment
molecular
farm
addit
materi
infecti
toward
mammal
ad
anoth
layer
safeti
factor
import
consider
move
toward
clinic
applic
commerci
genom
content
host
speci
shape
size
import
characterist
consid
choic
materi
use
section
highlight
design
guidelin
determin
desir
properti
deliveri
vector
nanomed
applic
icosahedr
virus
triangul
number
number
one
method
classif
give
indic
size
see
figur
number
first
describ
donald
caspar
aaron
klug
multipli
use
determin
number
coat
protein
capsid
exampl
viru
coat
protein
viru
coat
protein
protein
cluster
pentam
hexam
viru
icosahedr
symmetri
therefor
consist
pentam
hexam
size
play
factor
transport
clearanc
behavior
particl
well
amount
cargo
carri
deliv
cell
challeng
smaller
aav
nm
diamet
addit
shape
particl
affect
possibl
modif
function
could
appli
capsid
exampl
icosahedron
advantag
possess
interior
caviti
use
infus
encapsul
variou
payload
hand
high
aspect
ratio
particl
use
form
wire
appli
energi
applic
overal
clear
divers
librari
viru
particl
select
matter
applic
varieti
method
develop
product
viru
particl
discuss
manufactur
bacteria
yeast
insect
cell
plant
use
cellfre
system
start
one
wide
util
system
rapid
product
protein
eas
scaleup
escherichia
coli
although
prokaryot
system
also
consid
pseudomona
fluorescen
wealth
knowledg
surround
e
coli
product
make
popular
therefor
also
wide
appli
product
vlp
viral
coat
protein
express
spontan
selfassembl
bacteri
cell
demonstr
bacteriophag
well
heterolog
express
virus
plant
virusbas
tmv
mammalian
virusbas
hepat
b
viru
hbv
core
particl
note
vlp
form
way
contain
genom
content
also
empti
tend
packag
host
nucleic
acid
exampl
mass
vlp
system
undergon
clinic
test
consist
e
coli
rna
applic
packag
nucleic
acid
undersir
sever
method
develop
remov
nucleic
acid
compon
particl
assembl
method
includ
treatment
heavi
metal
lead
acet
incub
alkalin
condit
rna
hydrolysi
induct
osmot
shock
use
high
molar
sodium
sulfat
solut
anoth
approach
product
empti
vlp
vitro
assembl
coat
protein
subunit
product
e
coli
purif
vitro
assembl
also
way
overcom
challeng
insolubl
eukaryot
capsid
protein
bacteria
cell
result
accumul
inclus
bodi
digress
briefli
signific
note
headway
made
produc
solubl
eukaryot
cdna
viru
genom
even
vitro
rna
transcript
leav
plant
gentl
abras
agroinfiltr
inject
suspens
agrobacterium
tumefacien
bacteria
leav
also
use
molecular
farm
plant
bacteria
transfer
part
tumor
induc
plasmid
plant
cell
exploit
transient
express
gene
interest
note
medicago
inc
use
plantbas
approach
effici
product
vlpbase
vaccin
influenza
rabi
among
other
therapeut
zmapp
monoclon
antibodi
cocktail
ebola
viru
ebov
mapp
biopharmaceut
also
util
plant
product
agroinfiltr
replic
intact
vnp
bmv
demonstr
addit
viral
capsid
cpmv
complet
devoid
rna
either
viru
host
produc
way
wherea
bmv
product
util
plasmid
transient
express
bmv
rna
system
infect
plant
empti
cpmv
ecpmv
vlp
product
use
plasmid
encod
two
protein
found
suffici
precursor
cpmv
two
coat
protein
proteinas
proteolyt
process
mention
previous
consist
empti
vlp
product
vivo
demonstr
ecpmv
platform
asid
farm
plant
new
technolog
may
appli
futur
product
vlp
use
plant
cell
pack
transient
express
plant
suspens
cell
pack
cooki
suction
agrobacterium
contain
gene
protein
interest
appli
approach
proven
produc
high
yield
recombin
protein
appli
high
throughput
manner
make
attract
option
vlp
express
final
altern
vivo
approach
work
involv
vlp
product
use
cellfre
system
cellular
machineri
transcript
translat
use
protein
express
vitro
earli
work
area
util
eukaryot
system
base
rabbit
reticulocyt
studi
capsid
assembl
hepat
c
viru
hcv
hbv
three
primat
lentivirus
yield
quit
low
ng
sinc
explor
e
colibas
system
achiev
yield
around
truncat
hbv
core
antigen
vlp
product
almost
complet
solubl
make
excel
platform
rapid
vlp
product
addit
vlp
abl
form
use
system
coproduct
coat
protein
cytotox
protein
normal
natur
incorpor
exterior
capsid
facilit
infect
demonstr
advantag
cellfre
system
cytotox
protein
product
regul
rel
express
multipl
protein
cost
cellfre
system
goe
may
becom
commonli
appli
product
vlp
sinc
virus
evolv
protect
effici
deliv
nucleic
acid
cargo
abl
withstand
condit
requir
chemic
modif
retain
long
shelf
life
modif
interior
caviti
exterior
surfac
viral
capsid
util
allow
encapsul
sensit
compound
display
target
moieti
precis
defin
array
among
function
beauti
util
particl
recogn
effort
made
toward
mimick
nanoscal
architectur
selfassembl
protein
nanomateri
uniqu
genet
encod
protein
shell
architectur
virusbas
scaffold
allow
larg
rang
techniqu
use
tailor
modifi
materi
among
frequent
use
discuss
genet
engin
bioconjug
infus
biominer
selfassembl
figur
engin
capabl
improv
even
greater
divers
virusbas
viruslik
particl
creat
expand
possibl
applic
materi
coat
protein
vnp
determin
genet
code
nucleic
acid
sequenc
virus
rel
small
therefor
mani
genom
sequenc
well
character
use
genet
engin
insert
replac
residu
perform
add
function
group
cystein
mutant
popular
due
possibl
disulfid
linkag
associ
gold
bioconjug
thiolselect
chemistri
insert
unnatur
amino
acid
also
possibl
allow
divers
chemic
modif
addit
remov
residu
accomplish
singl
uniqu
reactiv
site
remain
coat
protein
asid
singl
residu
modif
larger
chang
insert
purif
tag
also
accomplish
exampl
due
affin
coordin
nickelnitrilotriacet
acid
ninta
polyhistidin
tag
express
viral
capsid
serv
anchor
applic
includ
tether
surfac
attach
particl
nanogold
iron
oxid
assembl
higherord
structur
display
short
peptid
sequenc
demonstr
includ
epitop
vaccin
moieti
target
receptor
whole
protein
protein
domain
insert
also
achiev
even
viru
hybrid
consist
coat
protein
express
differ
protein
establish
coinfect
plant
verif
bimolecular
fluoresc
complement
asid
genet
engin
viral
coat
protein
tag
antibodi
bind
peptid
genet
fuse
fluoresc
protein
enzym
protein
interest
particular
exampl
assembl
particl
display
protein
achiev
mean
intermediari
antibodi
specif
viral
coat
protein
conjug
strategi
target
natur
unnatur
amino
acid
viru
capsid
allow
mani
possibl
modif
may
achiev
genet
engin
alon
figur
interior
exterior
surfac
mani
virus
shown
amen
chemic
modif
common
group
function
includ
lysin
asparticglutam
acid
cystein
tyrosin
residu
lend
standard
bioconjug
reaction
involv
nhydroxysuccinimid
nh
ester
conjug
carbodiimid
activ
michael
addit
azo
coupl
chemistri
altern
natur
amino
acid
includ
replac
methionin
residu
homopropargyl
glycin
hpg
azidohomoalanin
aha
residu
add
alkyn
azid
function
respect
anoth
interest
method
util
mutant
trna
synthetas
attach
unnatur
amino
acid
amber
suppressor
trna
incorpor
amino
acid
amber
stop
codon
site
among
amino
acid
incorpor
way
omethyltyrosin
pazidophenylalanin
pacetylphenylalanin
pbenzoylphenylalanin
alanin
paminophenylalanin
paf
pazidophenylalanin
paf
particularli
noteworthi
due
provid
azid
amin
group
respect
select
coupl
reaction
note
incorpor
azid
alkyn
group
especi
widespread
strategi
conjug
handl
allow
copper
catalyz
azidealkyn
cycloaddit
cuaac
effici
biocompat
procedur
found
great
versatil
reaction
without
copper
catalysi
also
achiev
util
cyclooctyn
deriv
lower
activ
barrier
due
ring
strain
addit
reaction
handl
util
includ
aldehyd
keton
hydrazon
oxim
condens
reaction
select
format
aldehyd
keton
possibl
pyridox
plp
mediat
transamin
specif
nterminu
lead
situ
oxid
ntermin
amin
form
keton
aldehyd
group
use
form
stabl
oxim
linkag
alkoxyamin
avail
wide
rang
chemic
modifi
natur
unnatur
amino
acid
multipl
function
group
simultan
incorpor
within
singl
virusbas
particl
result
format
versatil
multifunct
platform
one
area
particl
modif
great
interest
format
proteinpolym
hybrid
conjug
polyethylen
glycol
peg
polym
frequent
use
shield
biolog
interact
attach
peg
aforement
bioconjug
techniqu
fairli
standard
sophist
polymer
chemistri
techniqu
also
shown
applic
polym
attach
virusbas
particl
widespread
applic
could
confer
advantag
better
effici
control
polydispers
atomtransf
radic
polymer
atrp
one
method
small
initi
ad
particl
first
polymer
capsid
carri
introduct
monom
result
easier
purif
smaller
reagent
well
overcom
challeng
steric
hindranc
larg
bulki
polym
incorpor
polym
use
method
proven
use
attach
complex
larg
payload
mr
contrast
agent
chemotherapeut
sirna
interior
exterior
modif
polym
could
also
synthes
first
atrp
attach
viral
capsid
display
glycoprotein
romp
anoth
method
biocompat
polym
synthesi
util
prepar
watersolubl
polynorbornenebas
polym
strict
size
architectur
control
good
safeti
profil
attach
deliv
fibroblast
cell
asid
chemistri
reli
coval
bond
supramolecular
chemistri
strategi
also
util
viru
modif
exampl
take
advantag
hydrophob
interior
allow
accommod
rang
guest
molecul
viru
particl
first
modifi
moieti
function
deriv
guest
molecul
approach
demonstr
use
deriv
adamantin
display
imag
agent
chemotherapeut
drug
target
ligand
peg
polym
similar
manner
chargetransf
interact
electron
donor
acceptor
also
use
derivat
viral
scaffold
illustr
attach
pyren
molecul
allow
particl
function
interact
electrondefici
dinitrophenyl
pyridinium
motif
interior
viral
capsid
use
cage
encapsul
foreign
cargo
virus
gener
flexibl
contain
pore
allow
diffus
small
molecul
drug
contrast
agent
capsid
retent
molecul
insid
capsid
achiev
electrostat
andor
affin
interact
nucleic
acid
within
shell
interact
polym
conjug
intern
encapsul
molecul
also
accomplish
gate
use
ph
metal
ion
concentr
trigger
structur
transit
use
gate
process
molecul
allow
diffus
particl
environ
capsid
swollen
open
conform
molecul
trap
within
capsid
pore
close
chang
buffer
condit
depend
desir
applic
molecul
interest
either
remain
encapsul
within
particl
releas
time
exampl
infus
imag
drug
deliveri
describ
section
anoth
applic
infus
introduc
metal
precursor
capsid
interior
miner
discuss
next
viral
particl
also
serv
templat
biominer
process
uniqu
size
shape
control
tune
electrostat
use
mineralizationdirect
peptid
nucleat
precursor
metal
ion
subsequ
shapeconstrain
miner
realiz
peptid
nucleat
binder
identifi
screen
use
phage
display
techniqu
variou
substrat
gaa
zn
shown
highli
specif
miner
demonstr
interior
exterior
surfac
particl
well
icosahedr
rodshap
virus
result
hybrid
inorganicorgan
materi
find
use
varieti
function
rang
applic
energi
semiconductor
see
section
medicin
contrast
agent
see
section
mostli
consid
virusbas
particl
intact
scaffold
build
also
taken
apart
reassembl
either
natur
genom
foreign
cargo
great
breadth
type
cargo
encapsul
selfassembl
includ
gold
nanoparticl
quantum
dot
photosensit
drug
sinc
coat
protein
natur
selfassembl
around
neg
charg
nucleic
acid
gener
neg
surfac
charg
result
effici
encapsul
foreign
cargo
nativ
packag
mechan
also
util
demonstr
ad
oligonucleotid
mimick
origin
assembl
rcnmv
packag
rna
variou
nanoparticl
induc
particl
format
around
differ
cargo
size
play
factor
assembl
due
effect
radiu
curvatur
differ
size
cargo
could
result
alter
morpholog
physic
characterist
capsid
seen
section
coat
protein
genet
modifi
incorpor
foreign
protein
cargo
particl
assembl
one
studi
fuse
coat
protein
ccmv
elastinlik
polypeptid
elp
exhibit
lower
critic
solut
temperatur
lcst
behavior
investig
found
two
differ
selfassembl
pathway
result
hybrid
vlp
consist
coat
protein
dimer
form
normal
phinduc
selfassembl
condit
nacl
concentr
increas
lower
elp
transit
temperatur
elpinduc
assembl
result
format
smaller
particl
consist
coat
protein
dimer
enzym
facilit
anoth
method
coat
protein
modif
demonstr
use
sortas
coval
attach
protein
ctermin
lpetg
tag
glycin
nterminu
ccmv
coat
protein
assembl
protein
encapsul
specif
bind
interact
coat
protein
also
exploit
selfassembl
engin
coiledcoil
protein
interact
establish
introduc
lysin
coil
nterminu
ccmv
associ
glutam
acid
coil
cterminu
fluoresc
protein
result
encapsul
protein
two
modifi
protein
combin
introduc
histidin
tag
affin
ninta
anoth
method
addit
interact
natur
exist
particl
includ
associ
scaffold
protein
bacteriophag
aid
viral
assembl
bind
translat
repress
oper
protein
rna
stemloop
within
bacteriophag
fusion
protein
util
encapsul
materi
interest
enzym
cascad
therapeut
molecul
virus
appli
broadli
medicin
diagnost
therapeut
purpos
mani
pipelin
undergo
clinic
trial
oncotherapi
gene
therapi
vector
fact
current
much
excit
recent
approv
oncotherapi
talimogen
laherparepvec
tvec
manufactur
amgen
tvec
discuss
detail
section
bacteriophag
plant
virus
particularli
attract
tool
biomed
applic
replic
within
mammalian
cell
therefor
platform
may
add
anoth
layer
safeti
section
explor
use
virusbas
particl
deliveri
vehicl
target
toward
imag
treatment
diseas
scaffold
interact
local
environ
util
vaccin
immunotherapi
tissu
engin
design
virus
applic
vivo
includ
charg
shape
surfac
ligand
present
figur
design
paramet
affect
circul
bodi
well
cellular
interact
tissu
specif
gener
principl
establish
specif
virusbas
particl
highlight
lesson
import
note
although
principl
provid
good
guidelin
vivo
studi
crucial
ascertain
new
propos
particl
behav
due
intricaci
complex
biolog
interact
fulli
predict
vitro
test
model
term
charg
appear
trend
virusbas
particl
neg
surfac
charg
tend
shorter
circul
time
observ
neg
charg
ccmv
cpmv
tmv
circul
halfliv
less
minut
comparison
halfliv
posit
charg
order
hour
effect
charg
plasma
clearanc
made
evid
much
quicker
clearanc
bacteriophag
observ
neutral
posit
lysin
residu
addit
revers
studi
singl
amino
acid
substitut
glutam
acid
residu
lysin
use
bacteriophag
result
higher
circul
time
notabl
except
trend
pvx
expect
longer
circul
base
posit
charg
abund
surfac
lysin
fact
quick
clearanc
halflif
around
minut
recent
studi
report
neg
zeta
potenti
pvx
like
due
differ
buffer
condit
use
indic
investig
charg
pvx
vivo
condit
crucial
confirm
whether
defi
convent
addit
influenc
base
charg
includ
alter
particl
interact
mammalian
cell
tumor
transport
rate
due
abund
presenc
proteoglycan
cell
membran
confer
neg
charg
collagen
within
tumor
interstiti
space
confer
posit
charg
posit
charg
particl
like
enhanc
bind
mammalian
cell
better
abl
avoid
aggreg
penetr
tumor
tissu
exampl
demonstr
chargebas
effect
includ
polyargininedecor
cpmv
found
taken
eight
time
effici
nativ
cpmv
human
cervic
cancer
cell
line
posit
charg
pvx
shown
abl
penetr
tumor
core
unlik
neg
charg
cpmv
latter
case
pvx
filament
natur
also
allow
better
avoid
macrophagocyt
system
lead
greater
tumor
home
like
shape
flexibl
pvx
play
addit
role
abil
diffus
throughout
tumor
comparison
diffus
profil
spheric
rodshap
particl
perform
cpmv
tmv
use
spheroid
model
shown
wherea
cpmv
experienc
steadi
diffus
profil
tmv
exhibit
twophas
diffus
behavior
entail
extrem
rapid
earli
load
phase
could
attribut
movement
axial
act
like
needl
advantag
properti
confer
elong
particl
includ
better
margin
toward
vessel
wall
stronger
adher
due
greater
surfac
area
interact
implic
tumor
home
also
enhanc
target
cardiovascular
diseas
shape
difficult
paramet
account
due
challeng
produc
monodispers
particl
precis
reproduc
tailor
nanoscal
challeng
surmount
use
vnp
vlp
due
specif
selfassembl
process
bottomup
assembl
approach
investig
recent
elucid
role
aspect
ratio
cell
uptak
biodistribut
tumor
home
one
approach
cpmv
particl
link
togeth
form
chain
order
maintain
charg
surfac
properti
modifi
aspect
ratio
dimer
aspect
ratio
found
target
cancer
cell
effici
singl
particl
higher
aspect
ratio
investig
anoth
studi
util
vitro
assembl
tmv
around
synthet
rna
form
rod
variou
length
nm
correspond
aspect
ratio
receptortarget
particl
modifi
rgd
ligand
rod
intermedi
aspect
ratio
found
effici
tumor
target
due
combin
better
macrophag
avoid
greater
adhes
target
integrin
compar
short
rod
better
diffus
within
tumor
compar
long
rod
base
aforement
spheroid
studi
tmv
like
three
aspect
ratio
experi
similar
axial
diffus
initi
rapid
phase
longer
particl
imped
slower
distribut
phase
contrast
pvx
particl
aspect
ratio
appear
hinder
length
fact
experi
better
penetr
relat
icosahedr
cpmv
possibl
reason
account
includ
thinner
crosssect
greater
flexibl
pvx
compar
tmv
expand
understand
role
shape
factor
densiti
flexibl
consid
futur
studi
surfac
present
shield
polym
also
play
role
vivo
behavior
virusbas
particl
peg
standard
polym
use
reduc
immunogen
nonspecif
cell
interact
import
polym
coat
particularli
appar
studi
highlight
differ
aspect
ratio
tmv
although
found
target
particl
fare
better
intermedi
size
coat
tmv
peg
allow
shorter
rod
better
abl
avoid
clearanc
pair
superior
diffus
properti
within
tumor
result
increas
passiv
tumor
target
short
nm
pegyl
rod
surfac
pegyl
appli
mani
vnp
establish
broadli
applic
method
extend
circul
time
addit
differ
rout
clearanc
also
observ
nonpegyl
tmv
pvx
filament
get
filter
kidney
pegyl
particl
like
due
increas
width
particl
conjug
prevent
renal
filtrat
conform
peg
coat
predict
comput
estim
surfac
coverag
particl
hydrodynam
radiu
determin
pack
densiti
polym
use
higher
molecular
weight
peg
gener
result
higher
hydrodynam
radiu
thu
better
shield
hydrodynam
radiu
averag
polym
extend
collaps
solut
despit
smaller
predict
radiu
branch
peg
multipl
site
attach
particl
shown
effect
shield
linear
peg
four
time
molecular
weight
like
simultan
tether
end
peg
trap
closer
particl
reduc
movement
possibl
nonspecif
protein
adsorpt
hypothes
branch
peg
lead
effici
shield
prevent
format
protein
corona
may
tag
virusbas
nanoparticl
recognit
innat
immun
system
lead
remov
circul
figur
therefor
dynam
peg
solut
also
consid
determin
conform
optim
particl
shield
polym
coat
also
studi
poli
n
methacrylamid
phpma
anoth
hydrophil
polym
use
particularli
aav
adenoviru
order
elimin
normal
infect
pathway
allow
redirect
virus
pathway
cation
polym
poli
amidoamin
pamam
dendrim
polyethyleneimin
also
explor
shield
infect
well
improv
transfect
effici
control
divers
polymer
chemistri
establish
graft
polym
viral
scaffold
use
atrp
romp
discuss
section
properti
vivo
yet
establish
use
serum
albumin
recent
investig
coat
tmv
shown
effect
mediumlength
peg
da
circul
time
greater
comparison
self
peptid
base
human
could
also
consid
inhibit
phagocyt
clearanc
nanoparticl
along
surfac
modif
allow
avoid
undesir
cell
interact
particl
enhanc
specif
cell
target
display
receptorspecif
diseas
environmentspecif
ligand
exampl
target
use
specif
uptak
virusbas
nanoparticl
includ
epiderm
growth
factor
receptor
egfr
folat
receptor
fr
manner
overexpress
receptor
environment
cue
track
diagnost
drug
deliveri
purpos
discuss
follow
section
obtain
favor
ligand
display
densiti
balanc
increas
avid
reduc
cellular
receptor
deplet
aris
increas
ligand
densiti
multival
higher
degre
label
target
ligand
benefici
stronger
cellular
interact
mani
ligand
may
reduc
extent
endocytosi
exhaust
cellular
receptor
anoth
design
paramet
inclus
target
ligand
linker
use
attach
exampl
inclus
peg
assist
increas
circul
time
avoid
nonspecif
discuss
addit
peg
linker
improv
cell
target
ad
flexibl
enhanc
present
target
peptid
alter
characterist
linker
interact
ligand
target
overal
behavior
particl
vivo
tune
use
tissuespecif
imag
deliveri
contrast
agent
applic
optic
imag
magnet
reson
imag
mri
positron
emiss
tomographi
pet
util
use
virus
imag
probe
come
ivers
approach
modif
particl
well
eas
precis
assembl
addit
clearanc
remov
bodi
critic
prevent
toxic
tissu
retent
contrast
agent
mani
vnp
platform
tend
clear
quickli
bodi
halflif
minut
compar
synthet
materi
requir
month
clearanc
carbon
nanotub
gold
silica
imag
import
tool
medicin
diagnost
visual
diseas
local
progress
well
treatment
success
improv
imag
technolog
earlier
diseas
detect
better
prognosi
realiz
abil
track
particl
aid
evalu
drug
deliveri
platform
use
confirm
cellspecif
uptak
investig
interact
particl
within
bodi
clearanc
biodistribut
immunogen
fluoresc
imag
main
modal
preclin
evalu
use
aid
establish
design
rule
section
fluoresc
agent
incorpor
viral
capsid
bioconjug
genet
engin
infus
selfassembl
fluoresc
use
quantif
particl
uptak
use
flow
cytometri
visual
particl
local
confoc
microscopi
determin
biodistribut
use
vivo
imag
although
high
dye
densiti
easili
achiev
effici
capsid
modif
strategi
sensit
decreas
certain
threshold
due
fluorophor
experienc
quench
place
distanc
less
approxim
nm
therefor
fairli
low
densiti
around
ideal
achiev
optim
fluoresc
intens
encapsul
indocyanin
green
util
method
near
infrar
nir
photoacoust
imag
shown
greater
photost
compar
chromophor
alon
advanc
made
anoth
aspect
could
explor
integr
gold
nanoparticl
fluorophor
metalenhanc
fluoresc
improv
quantum
yield
decreas
photobleach
first
iter
nativ
pegyl
particl
directli
evalu
biodistribut
pharmacokinet
tumor
home
behavior
fluoresc
imag
overal
particl
clear
mainli
liver
spleen
filament
particl
higher
rate
spleen
clearanc
compar
icosahedra
l
particl
local
b
cell
within
white
pulp
time
due
leaki
vasculatur
poor
lymphat
drainag
enhanc
permeabl
retent
epr
effect
found
solid
tumor
util
tumor
imag
nanoparticl
deposit
use
mous
chicken
chorioallanto
membran
cam
model
tumor
xenograft
passiv
partit
particl
tumor
observ
figur
discuss
previou
section
evalu
local
particl
insid
tumor
reveal
enhanc
accumul
penetr
rodshap
particl
besid
passiv
tumor
home
properti
natur
interact
virus
certain
cell
also
exploit
cpmv
particular
exhibit
uniqu
specif
interact
surfac
vimentin
found
endotheli
cancer
inflammatori
cell
nativ
affin
cpmv
surfac
vimentin
allow
highresolut
imag
microvasculatur
depth
achiev
use
nanoparticl
tend
aggreg
block
vasculatur
interact
util
rang
applic
deliveri
panel
cancer
cell
includ
cervic
breast
colon
cancer
cell
line
delin
atherosclerot
lesion
intravit
imag
tumor
vasculatur
angiogenesi
anoth
exampl
exist
endogen
associ
cpv
transferrin
receptor
tfr
import
receptor
iron
transport
cell
highli
upregul
numer
cancer
cell
line
even
dye
label
cpv
retain
specif
tfr
shown
bind
receptor
found
hela
cervic
cancer
cell
colon
cancer
cell
breast
cancer
cell
quick
side
note
vivo
imag
bacteri
infect
differenti
fposit
fneg
e
coli
strain
also
possibl
specif
bind
phage
specif
also
introduc
incorpor
target
ligand
molecular
imag
rgd
target
peptid
frequent
use
due
high
affin
v
v
integrin
involv
angiogenesi
associ
cancer
prolifer
associ
rgdtarget
particl
tumor
vascular
endothelium
demonstr
mice
although
studi
also
indic
better
tumor
local
would
achiev
greater
circul
time
impart
incorpor
better
shield
linker
see
section
cpmv
display
peptid
discov
phage
display
use
target
vascular
endotheli
growth
fa
ctor
accumul
throughout
tumor
observ
compar
detect
uptak
nontarget
particl
option
explor
includ
fr
target
folic
acid
fa
tfr
transferrin
prostat
specif
membran
antigen
psma
psma
antibodi
recent
year
target
approach
mani
angl
epiderm
growth
factor
receptor
egfr
import
biomark
overexpress
mani
malign
cell
type
strategi
rang
display
egf
genet
engin
use
phage
antibodi
librari
select
fd
phage
singlechain
antibodi
variabl
fragment
scfv
specif
egfr
well
relat
receptor
human
epiderm
growth
factor
receptor
conjug
egfr
antibodi
also
chemic
attach
peptid
pvx
studi
evalu
cell
bind
vitro
promis
result
indic
partit
target
particl
tumor
cell
compar
macrophag
cocultur
would
interest
see
develop
mous
model
outsid
membran
protein
cancer
cell
protein
highli
express
activ
endotheli
cell
vascular
cell
adhes
molecul
vcam
util
target
imag
cardiovascular
diseas
atherosclerot
plaqu
beyond
strategi
matrix
secret
protein
also
advantag
target
exampl
collagen
secret
protein
acid
rich
cystein
sparc
extracellular
matrix
glycoprotein
detect
tumor
imag
targetspecif
peptid
display
sparc
particular
success
target
deep
tissu
imag
lung
cancer
even
use
guid
resect
ovarian
cancer
pair
fluoresc
singlewal
carbon
nanotub
swnt
allow
nonphotobleach
fluoresc
less
background
second
nir
window
rang
nm
polymer
fibrin
found
thrombi
also
investig
delin
blood
clot
use
cpmv
tmv
equip
gprpp
creka
pentapeptid
amino
acid
sequenc
studi
investig
imag
thrombosi
atherosclerosi
establish
targetspecif
imag
optic
also
mr
imag
mri
clinic
relev
method
noninvas
diseas
character
good
soft
tissu
contrast
use
contrast
agent
conjunct
mr
improv
signaltonois
ratio
highlight
differ
diseas
normal
tissu
gadolinium
one
paramagnet
contrast
agent
use
achiev
brighter
signal
weight
imag
molecular
imag
atherosclerot
plaqu
achiev
dosag
time
lower
clinic
use
angiographi
encapsul
gd
chelat
acid
gd
dota
within
tmv
target
high
contrast
attribut
high
payload
gdtmv
slower
molecular
tumbl
rate
result
attach
gd
dota
macromolecul
inclus
target
peptid
advantag
impart
shape
tmv
drift
later
vessel
wall
latest
result
culmin
numer
studi
sever
group
form
step
stone
along
way
earli
work
look
direct
bind
gd
natur
metal
bind
site
capsid
ccmv
use
chelat
bioconjug
quickli
introduc
mitig
concern
free
gd
lead
toxic
patient
underli
kidney
diseas
explor
use
dota
diethylenetriaminepentaacet
acid
dtpa
approach
result
per
particl
relax
order
mm
measur
mhz
fairli
high
much
greater
mm
gd
alon
valu
approach
measur
around
mm
per
particl
initi
studi
direct
attach
gd
improv
contrast
interior
exterior
label
well
rigid
linker
explor
use
chelat
base
hydroxypyridinon
hopo
due
relax
enhanc
compar
clinic
use
magnevist
gd
dtpa
intern
modifi
capsid
rigid
linker
particular
enantiom
demonstr
approxim
higher
relax
enhanc
gd
load
anoth
method
explor
increas
per
particl
relax
either
use
atrp
amplifi
densiti
group
attach
contrast
agent
use
branch
oligom
multipl
gd
dtpa
complex
attach
greatest
success
approach
led
incorpor
gd
dtpa
per
particl
per
particl
relax
exceed
mm
vivo
imag
first
demonstr
use
conjug
gd
dtpa
order
visual
blood
vessel
mous
clear
depict
carotid
arteri
mammari
arteri
jugular
vein
vein
head
resolut
recent
relax
approach
mm
per
particl
report
util
tmv
greater
surfac
area
confer
shape
introduc
larg
payload
gd
dota
accompani
thermal
transit
rod
use
condit
result
nm
sphere
coat
interiorli
label
tmv
particl
silica
could
potenti
increas
relax
well
lead
greater
macrophag
uptak
henc
contrast
expect
combin
research
direct
investig
chelat
linker
conjug
shape
shift
coat
result
particl
even
greater
contrast
better
visual
diseas
apart
gdbase
contrast
enhanc
manganes
iron
oxid
contrast
agent
investig
manganes
research
rel
new
label
mn
porphyrin
shown
per
particl
relax
mm
mhz
low
compar
advanc
gd
imag
promis
avenu
pursu
due
reduc
toxic
mn
unlik
gd
mn
iron
oxid
contrast
agent
weight
imag
observ
result
darker
imag
interestingli
first
demonstr
mr
imag
iron
oxid
plant
cubic
iron
oxid
nanoparticl
encapsul
within
bmv
nicotiana
benthamiana
leav
infiltr
modifi
viru
imag
perform
celltocel
traffick
encapsul
iron
oxid
observ
encapsul
iron
oxid
nanoparticl
phantom
imag
demonstr
hepat
b
core
vlp
move
toward
translat
attach
iron
oxid
nanoparticl
along
sparc
bind
peptid
surfac
effect
imag
prostat
cancer
figur
anoth
mr
contrast
approach
quit
new
chemic
exchang
satur
transfer
cest
hypercest
imag
xenonbas
agent
particular
explor
virus
select
satur
nuclei
enhanc
water
signal
observ
due
satur
transfer
surround
bulk
water
techniqu
found
success
fd
sensit
low
fm
addit
incorpor
scfv
recogn
egfr
molecular
imag
contrast
specif
demonstr
cancer
cell
essenti
contrast
jurkat
neg
control
cell
due
increas
sensit
lot
potenti
new
technolog
pet
imag
anoth
sensit
imag
modal
reli
detect
radiotrac
util
ascertain
biodistribut
nonpegyl
pegyl
capsid
incorpor
f
fluorobenzaldehyd
cu
chelat
dota
respect
take
step
biodistribut
encapsul
nonencapsul
superparamagnet
iron
oxid
nanoparticl
f
polyllysin
pll
cation
packag
f
within
hemagglutin
viru
japan
envelop
hvje
studi
determin
whether
magnet
stimulu
use
redirect
virus
head
clear
applic
magnet
alter
fate
virus
increas
signal
head
target
ligand
also
explor
conjunct
pet
imag
rgd
target
human
sarcoma
glioma
xenograft
target
egfr
posit
liver
cancer
xenograft
model
context
virusbas
particl
less
work
pet
compar
imag
modal
pet
advantag
high
sensit
abil
imag
deepli
radiotox
issu
purpos
simpli
detect
particl
local
diagnost
mri
may
ideal
pursu
technolog
improv
begin
foray
viral
vector
combat
diseas
start
vaccin
extens
histori
like
first
medic
applic
virus
popular
illustri
begin
edward
jenner
experi
inocul
garden
eightyearold
son
cowpox
result
protect
boy
subsequ
challeng
seriou
smallpox
viru
knowledg
virus
would
come
year
later
work
dmitri
ivanovski
martinu
beijerinck
filter
tmv
plant
sap
demonstr
infect
replic
medic
applic
virus
root
instead
live
virus
safer
altern
vaccin
sinc
establish
includ
attenu
virus
inactiv
subunit
virus
noninfecti
vlp
nanoparticl
deliveri
nucleic
acid
vaccin
vaccin
research
wide
rang
diseas
great
success
diseas
polio
measl
import
vaccin
hiv
ebov
still
lack
discuss
elicit
effect
longterm
immun
respons
one
challeng
vaccin
use
viru
capsid
offer
advantag
multival
antigen
present
incorpor
multipl
epitop
particl
stabil
sinc
field
enorm
would
like
featur
research
vaccin
focus
studi
area
infecti
diseas
brain
disord
cancer
comprehens
overview
virusbas
particl
vaccin
reader
invit
consult
review
realm
infecti
diseas
hiv
particularli
challeng
address
due
sequenc
divers
difficulti
gener
broadli
neutral
antibodi
like
partial
due
structur
characterist
consist
low
number
envelop
spike
allow
escap
recognit
foreign
increas
likelihood
evolv
envelop
determin
mimic
self
high
densiti
display
hiv
antigen
one
method
combat
trimer
glycoprotein
well
precursor
highli
target
exampl
recent
investig
studi
effect
present
particularli
conserv
membraneproxim
extern
region
mper
vlp
approach
produc
antimp
antibodi
show
neutral
activ
rabbit
model
albeit
moder
product
neutral
antibodi
valuabl
therapeut
respons
could
improv
modifi
mper
present
anoth
potenti
target
vaccin
cellular
selfprotein
found
involv
coreceptor
hiv
replic
pathogenesi
highdens
display
peptid
result
high
igg
antibodi
titer
abl
protect
rhesu
macaqu
intravagin
challeng
highli
virul
strain
term
potenti
vaccin
undergo
clinic
trial
success
seen
use
treatment
combin
alvac
canarypox
vector
vaccin
booster
aidsvax
subunit
vaccin
vaccin
efficaci
observ
studi
consist
subject
thailand
work
still
remain
done
improv
efficaci
hiv
vaccin
great
stride
made
recent
year
toward
realiz
anoth
area
vaccin
product
great
interest
protect
highli
virul
deadli
ebov
ebola
vlp
gener
consist
glycoprotein
nucleoprotein
matrix
protein
viru
use
baculoviru
express
system
cynomolgu
macaqu
vaccin
vlp
complet
protect
lethal
ebov
challeng
strong
cell
respons
like
contribut
investig
ebola
vlp
consist
glycoprotein
also
produc
insect
cell
demonstr
potenti
deliveri
without
adjuv
reveal
strong
immun
respons
protect
lethal
challeng
mice
high
dose
util
optim
still
need
enhanc
immunogen
prospect
includ
improv
glycoprotein
incorpor
vlp
assembl
includ
immunostimulatori
molecul
within
particl
potenti
safer
altern
ebola
vlp
use
virus
display
ebov
antigen
instead
vesicular
stomat
viru
vsv
one
viru
studi
use
highli
attenu
form
vsv
genet
engin
incorpor
ebov
glycoprotein
place
effect
strategi
singl
dose
suffici
protect
guinea
pig
macaqu
challeng
result
highli
encourag
interest
see
effect
protect
strain
ebov
asid
vaccin
human
viral
infect
great
interest
investig
anim
vaccin
well
protect
pet
livestock
earli
studi
insert
short
epitop
capsid
protein
mink
enteri
viru
mev
within
capsid
cpmv
found
impart
protect
immun
clinic
diseas
mink
dose
mg
offer
complet
protect
also
reduc
shed
viru
sinc
epitop
occur
canin
parvoviru
felin
panleukopenia
viru
well
platform
could
use
protect
mink
dog
cat
anoth
exampl
footandmouth
diseas
viru
fmdv
highli
infecti
viru
affect
clovenhoof
anim
cattl
sheep
import
farm
empti
fmdv
capsid
produc
use
baculoviru
system
test
guinea
pig
abl
gener
neutral
antibodi
fmdv
lower
level
commerci
inactiv
vaccin
still
good
antigen
immunogen
use
crude
protein
extract
may
result
lower
particl
quantiti
experiment
setup
thu
result
excit
use
noninfecti
empti
capsid
treat
fmdv
bluetongu
viru
btv
anoth
problemat
diseas
detriment
agricultur
industri
due
high
morbid
mortal
affect
rumin
sheep
cattl
vlp
btv
produc
use
baculoviru
express
system
found
protect
infect
test
sheep
effect
deliveri
singleserotyp
multiserotyp
cocktail
interfer
observ
presenc
antibodi
serotyp
btv
vlp
also
assembl
plant
use
cpmvbase
hypertran
vector
system
vaccin
vlp
provid
protect
btv
challeng
particl
found
elicit
strong
antibodi
respons
sheep
booster
dose
compar
live
attenu
viru
use
commerci
vaccin
develop
vaccin
plantbas
system
could
result
cheap
easili
scalabl
product
without
danger
anim
pathogen
contamin
interestingli
vaccin
also
appli
brain
disord
addict
alzheim
diseas
nicotin
tobacco
use
common
drug
addict
worldwid
reduct
nicotin
transport
brain
found
decreas
depend
drug
due
reduc
stimul
mesolimb
reward
system
nicotin
coval
coupl
result
high
drugspecif
igg
antibodi
product
vaccin
mice
bind
antibodi
nicotin
caus
decreas
nicotin
level
brain
individu
mice
phase
trial
found
approach
safe
well
toler
high
antibodi
product
nicotin
individu
phase
ii
trial
demonstr
nicotin
vaccin
effect
patient
quit
smoke
still
room
improv
antibodi
titer
greater
efficaci
turn
alzheim
diseas
peptid
deposit
associ
develop
neurodegen
disord
target
vaccin
reduc
aggreg
amelior
symptom
one
studi
hepat
b
viru
core
protein
display
two
acid
fragment
taken
nterminu
assembl
chimer
vlp
use
immun
alzheim
transgen
mous
model
without
inclus
addit
adjuv
vlp
elicit
potent
humor
respons
reduc
deposit
microgliosi
result
improv
learn
memori
immun
mice
readili
learn
rememb
locat
hidden
platform
morri
water
maze
anoth
therapeut
potenti
alzheim
diseas
vaccin
display
first
six
amino
acid
undergo
phase
ii
test
longterm
treatment
patient
mild
alzheim
diseas
overal
multipl
exposur
result
prolong
time
antibodi
titer
declin
treatment
favor
safeti
toler
profil
occurr
sever
advers
respons
found
antibodi
therapi
meningoenceph
autoimmun
diseas
time
need
observ
longterm
treatment
effect
vaccin
far
result
promis
final
look
treatment
cancer
differ
immunotherapi
approach
recent
merck
brought
gardasil
market
hpv
vaccin
upgrad
gardasil
protect
serotyp
hpv
account
hpvrelat
cancer
fantast
news
altern
necessari
due
issu
cost
distribut
develop
world
commerci
vaccin
vlp
deriv
major
capsid
protein
hpv
conserv
across
serotyp
thu
simpler
approach
broadli
protect
would
ideal
exampl
effort
made
produc
highli
immunogen
vlp
stabl
time
without
refriger
although
minor
capsid
protein
hpv
less
expos
less
immunogen
highli
conserv
across
serotyp
display
short
peptid
hpv
type
work
particularli
well
preclin
mous
model
reconstitut
viru
spray
dri
remain
highli
immunogen
without
use
adjuv
even
month
storag
room
temperatur
mice
vaccin
vlp
addit
protect
heterolog
hpv
pseudovirion
type
gardasil
protect
type
vaccin
also
use
protect
stimul
immun
system
cancer
cell
receptor
overexpress
breast
cancer
tend
aggress
one
potenti
target
cancer
immunotherapi
present
bcell
epitop
extracellular
domain
pvx
led
higher
antibodi
titer
specif
compar
solubl
peptid
alon
pvxbase
carrier
promis
vaccin
due
tropism
toward
b
cell
larg
surfac
area
impart
filament
natur
lead
high
multival
differ
approach
cancer
cell
result
cell
mediat
tumor
prevent
util
associ
minor
capsid
protein
murin
polyomaviru
mpyv
intern
surfac
major
capsid
protein
coat
protein
fuse
particl
assembl
way
immun
mice
vlp
result
antibodi
hand
vlp
induc
product
cell
autochthon
breast
cancer
mous
model
model
mice
challeng
cell
model
cell
complet
protect
tumor
growth
observ
mice
therefor
potenti
approach
potent
prophylact
vaccin
cancer
besid
cell
surfac
receptor
tn
antigen
tumorassoci
carbohydr
antigen
wide
explor
present
viral
capsid
investig
util
particl
cpmv
tmv
although
tn
one
weakest
antigen
strateg
pattern
display
antigen
abl
induc
potent
humor
immun
respons
recogn
human
tumor
cell
evalu
tn
present
vivo
cancer
protect
essenti
next
step
carri
forward
cancer
vaccin
therapeut
clear
take
advantag
bodi
natur
immun
system
myriad
applic
virusbas
vaccin
realiz
would
like
briefli
highlight
applic
virus
immunotherapi
well
especi
recent
groundbreak
approv
first
oncolyt
viru
ov
cancer
therapi
fda
octob
tvec
approv
treatment
melanoma
patient
viral
vector
base
hsv
type
mechan
action
ov
yet
well
understood
appear
involv
lysi
rapid
replic
within
tumor
cell
well
promot
system
antitumor
immun
respons
tvec
encod
granulocytemacrophag
colonystimul
factor
gmcsf
cytokin
involv
dendrit
cell
recruit
matur
aid
addit
stimul
antitumor
immun
phase
iii
clinic
trial
treatment
tvec
led
durabl
respons
even
patient
advanc
stage
iv
diseas
approv
tvec
signific
step
forward
futur
investig
import
enhanc
efficaci
combin
approach
figur
well
establish
safeti
profil
regulatori
guidelin
inform
action
ov
recent
develop
field
pleas
refer
follow
review
final
exampl
effect
viru
particl
immunostimul
recent
studi
collabor
fier
lab
darmouth
univers
demonstr
situ
vaccin
tumor
ecpmv
capsid
without
nucleic
acid
modif
could
help
overcom
immunosuppress
tumor
microenviron
treatment
ecpmv
led
reduct
even
regress
tumor
growth
metastasi
varieti
mous
model
includ
melanoma
ovarian
carcinoma
colon
cancer
breast
carcinoma
ecpmv
found
specif
target
activ
neutrophil
tumor
microenviron
lead
strong
rapid
antitumor
respons
respons
found
system
durabl
mice
elimin
primari
melanoma
tumor
ecpmvmedi
immun
resist
rechalleng
three
four
mice
complet
reject
tumor
figur
system
protect
like
result
immun
memori
tumor
antigen
mediat
cell
result
establish
unmodifi
ecpmv
therefor
open
opportun
enhanc
efficaci
display
antigen
inclus
adjuv
chemotherapeut
overal
still
difficulti
exist
develop
vaccin
target
chronic
diseas
cancer
infecti
diseas
progress
made
recent
result
show
great
promis
efficaci
novel
vaccin
potenti
vlp
vaccin
immunotherapi
quit
evid
opportun
treatment
infecti
diseas
also
addict
brain
disord
cancer
addit
vaccin
virus
appli
deliveri
fulllength
dna
small
interf
rna
machineri
genom
edit
nucleas
treatment
wide
rang
disord
gene
deliveri
long
histori
begin
initi
conceptu
year
ago
sinc
extens
bodi
work
dedic
realiz
gene
therapi
treatment
diseas
parkinson
diseas
cystic
fibrosi
hemophilia
cancer
exampl
extens
gene
therapi
gener
public
start
becom
realist
approv
uniqur
glybera
clinic
use
europ
open
door
bring
gene
therapi
market
aav
therapi
deliv
lipoprotein
lipas
gene
make
defici
patient
process
triglycerid
gene
therapi
pois
push
toward
commerci
come
year
among
includ
aav
gene
therapi
spark
therapeut
treatment
leber
congenit
amaurosi
visual
impair
caus
defect
gene
base
lack
seriou
advers
event
initi
studi
posit
phase
iii
trial
result
expect
advanc
toward
file
biolog
licens
applic
us
food
drug
administr
road
point
certainli
easi
tragedi
strike
jess
gelsing
die
clinic
trial
massiv
immun
respons
instig
adenovir
vector
meant
correct
ornithin
transcarbamoylas
metabol
defici
year
later
despit
great
success
mani
children
retrovirusbas
gene
treatment
xlink
sever
combin
immunodefici
result
develop
leukemia
sever
young
children
result
gene
insert
near
oncogen
despit
misfortun
discourag
result
past
research
led
better
understand
gene
deliveri
potenti
pitfal
overcom
lead
lot
control
accomplish
purpos
gene
deliveri
less
sever
fewer
advers
effect
due
plethora
work
done
area
mean
comprehens
review
gene
deliveri
mani
excel
review
invit
reader
consult
howev
take
glimps
studi
demonstr
breadth
field
excit
studi
perform
focu
recent
develop
improv
safeti
profil
adenoviru
retarget
cellspecif
deliveri
well
progress
util
nonmammalian
virus
gene
deliveri
adenoviru
icosahedr
nonenvelop
viru
core
diamet
nm
fiber
extend
penton
base
allow
attach
host
cell
coxsackieadenoviru
receptor
car
see
figur
follow
bind
adenoviru
bind
integrin
receptor
rgd
display
base
fiber
specif
adenoviru
mammalian
cell
util
gene
therapi
case
glioblastoma
highli
aggress
brain
cancer
abil
prolong
time
death
reintervent
tactic
work
inject
adenoviru
contain
cdna
herp
simplex
viru
thymidin
kinas
hsvtk
around
lesion
surgic
resect
tumor
follow
system
deliveri
prodrug
ganciclovir
cell
transduc
hsvtk
phosphoryl
prodrug
ganciclovir
triphosph
cytotox
nucleotid
analogu
becom
incorpor
dna
activ
prolifer
cell
adenoviru
gene
deliveri
also
util
antivir
therapeut
rna
interfer
rnai
demonstr
hbv
use
deliveri
antihbv
primari
microrna
primir
cassett
driven
murin
transthyretin
mttr
promot
promot
liverspecif
transcript
regulatori
element
impart
high
specif
bare
detect
express
nonliv
cell
furthermor
express
antihbv
primir
result
knockdown
hbv
replic
mice
altern
adenoviru
deliveri
aav
particularli
popular
due
low
immunogen
inabl
selfrepl
capac
target
nondivid
cell
stereotact
deliveri
nerv
growth
factor
ngf
nucleu
basali
neuron
basal
forebrain
shown
welltoler
method
longterm
ngf
express
purpos
protect
patient
alzheim
diseas
neural
degener
aav
vector
addit
provid
protect
simianhuman
immunodefici
viru
shiv
deliveri
transgen
encod
bind
envelop
glycoprotein
well
coreceptor
high
avid
protect
multipl
infecti
dose
shiv
confer
rhesu
macaqu
aav
phage
hybrid
aavp
also
creat
order
combin
target
potenti
phage
transgen
express
effici
aav
insert
cisregulatori
element
aav
phage
vector
genom
flank
transgen
cassett
use
hsvtk
ganciclovir
approach
describ
adenoviru
aavp
display
rgd
peptid
abl
home
sarcoma
cell
instig
transgen
express
tumor
regress
rat
human
softtissu
sarcoma
xenograft
model
similar
outcom
combin
target
transfect
also
achiev
coval
coat
adenoviru
hydrophil
polym
result
retarget
viru
well
protect
antibodi
neutral
high
immunogen
one
downfal
adenoviru
deliveri
result
mainli
intravascular
inject
antibodi
produc
primarili
hexon
capsid
protein
adenoviru
still
util
local
administr
shield
hexon
incorpor
target
ligand
system
deliveri
target
select
independ
car
made
possibl
aminereact
phpmabas
polym
mention
previous
section
use
adenoviru
coat
modif
viru
target
ligand
basic
fibroblast
growth
factor
bfgf
vascular
endotheli
growth
factor
vegf
antibodi
eselectin
pselectin
glycoprotein
fuse
fc
demonstr
retarget
adenoviru
cancer
cell
tumorassoci
vasculatur
addit
phpmacoat
adenoviru
activat
cell
penetr
peptid
attach
enabl
cytoplasm
deliveri
viru
metalloproteinaseoverexpress
tumor
cell
transduct
phpma
copolym
coat
shown
maintain
cell
cultur
also
vivo
mous
model
peg
also
shown
effect
polym
shield
retarget
improv
simpl
peg
coat
complex
copolym
peg
pei
result
abil
transduc
carneg
nih
cell
ad
benefit
less
toxic
compar
pei
alon
asid
pei
cation
poli
amidoamin
pamam
dendrim
also
use
enhanc
gene
deliveri
addit
egfrspecif
ligand
dendrimerco
adenoviru
carri
sodium
iodid
symport
gene
ni
success
appli
radiovirotherapi
liver
cancer
xenograft
mous
model
addit
take
advantag
iodid
pet
imag
viral
distribut
mammalian
virus
machineri
gene
transduct
phage
plant
virus
also
hold
potenti
gene
deliveri
gene
silenc
earli
phage
gene
deliveri
report
target
egf
mammalian
gene
cassett
insert
vector
backbon
transduct
low
could
improv
use
multival
phagemidbas
vector
discuss
section
genotox
treatment
heat
shock
uv
irradi
camptothecin
treatment
practic
method
overcom
cellular
barrier
mammalian
cell
inspir
hbv
taken
region
hbv
envelop
protein
involv
viru
attach
infect
display
bacteriophag
result
effici
gene
transfer
test
human
hepatocellular
carcinoma
cell
anoth
hybrid
phage
complex
time
cation
polym
polydlysin
pdl
diethylaminoethyldextran
deaedex
also
abl
improv
transgen
express
cell
type
specif
retain
display
rgd
gene
deliveri
plant
virus
begin
take
shape
recent
demonstr
assembl
ccmv
coat
protein
around
heterolog
rna
deriv
sindbi
viru
sinv
shown
releas
cytoplasm
mammalian
cell
codeliveri
figur
gene
silenc
phage
especi
popular
packag
rna
encapsul
cocktail
anticyclin
small
interf
rna
sirna
silenc
express
cyclin
cyclin
cyclin
cyclin
shown
protect
rna
degrad
month
store
fridg
target
vlp
hepatocellular
carcinoma
cell
result
induc
apoptosi
cell
pm
sirna
concentr
substanti
effect
viabil
normal
hepatocyt
sirna
deliveri
corrobor
deliveri
sirna
packag
within
target
tfr
hela
cell
caus
enhanc
gene
knockdown
apoptosi
compar
nontarget
particl
effect
similar
commerci
lipid
transfect
reagent
mirnamedi
rna
interfer
rnai
also
explor
conjug
tat
peptid
shown
abl
effect
transfer
encapsul
premirna
rang
cell
line
tissu
type
process
matur
mirna
subsequ
suppress
express
specif
target
gene
group
also
show
packag
antisens
rna
deliv
tat
peptid
inhibit
hepat
c
viru
hcv
rna
translat
far
studi
mainli
proofofconcept
suggest
vlp
much
potenti
gene
deliveri
system
mani
direct
gene
therapi
applic
addit
gene
deliveri
virus
also
use
deliveri
drug
virus
appli
carrier
therapeut
cargo
phototherm
therapi
photodynam
therapi
pdt
chemotherapi
phototherm
therapi
area
whose
potenti
bare
tap
viru
realm
gener
heat
produc
metal
nanostructur
absorpt
nir
infrar
light
induc
hyperthermia
util
kill
suscept
tumor
cell
use
approach
treatment
appli
specif
area
toxic
elsewher
reduc
far
one
studi
nm
gold
coval
attach
adenoviru
deliv
hela
cell
possibl
use
virusbas
particl
combin
phototherm
gene
cancer
therapi
discuss
studi
sinc
also
success
attach
gold
vnp
phototherm
therapi
use
formul
yet
explor
photodynam
therapi
like
phototherm
therapi
util
light
trigger
except
effect
creat
local
cytotox
reactiv
oxygen
speci
ro
therapi
initi
pdt
appli
antimicrobi
approach
use
ccmv
function
rutheniumbas
photosensit
direct
staphylococcu
aureu
use
electrostat
approach
pll
target
approach
antibodi
protein
present
cell
wall
pdt
demonstr
standard
antimicrobi
fluenc
rate
j
cm
cell
reduct
order
magnitud
observ
select
impart
use
antiprotein
target
sinc
pdt
appli
therapeut
cancer
cell
buckybal
c
attach
cpmv
improv
solubil
photosensit
aid
deliveri
treatment
prostat
cancer
cell
intern
conjug
porphyrin
combin
extern
display
aptam
protein
tyrosin
kinas
receptor
jurkat
leukemia
cell
establish
select
kill
jurkat
cell
cultur
erythrocyt
min
illumin
nm
addit
proofofconcept
studi
glycan
decor
shown
effect
strategi
target
cell
bear
receptor
involv
regul
b
cell
illustr
deliveri
metalloporphyrin
specif
elimin
cell
move
toward
clinic
applic
pdt
use
photosens
excit
nir
rang
would
ideal
better
tissu
penetr
phthalocyanin
dye
one
class
photosensit
selfassembl
ccmv
phthalocyanin
encapsul
explor
recent
ccmv
coencapsul
gd
dota
micel
phthalocyanin
dye
result
better
capsid
stabil
impart
possibl
perform
combin
therapi
mr
imag
thu
remain
investig
potenti
valu
pdt
virusbas
nanoparticl
also
develop
deliveri
chemotherapi
chemotherapi
associ
doselimit
toxic
specif
deliveri
cancer
cell
use
carrier
system
increas
safeti
well
target
payload
deliveri
particular
doxorubicin
dox
deliveri
studi
extens
like
popular
part
due
clinic
success
doxil
liposom
formul
dox
dox
work
intercal
dna
caus
oxid
dna
damag
conjug
dox
achiev
phcleavabl
hydrazon
linkag
demonstr
one
studi
alkynefunction
hydrazon
linker
use
attach
azidefunction
polym
grown
capsid
atrp
manner
dox
could
subsequ
releas
low
ph
cleavag
linker
particl
uptak
shown
maintain
efficaci
kill
hela
cell
method
conjug
also
recent
establish
sphere
made
thermal
transit
tmv
util
load
doxorubicin
found
effect
chemotherapeut
deliveri
breast
cancer
cell
besid
chemic
conjug
dox
load
infus
rcnmv
incorpor
fibrou
matrix
made
polylact
acid
pla
polyethylen
oxid
peo
nanofib
combin
two
system
could
tailor
result
either
twophas
releas
profil
first
order
releas
profil
depend
whether
viru
cospun
fiber
matrix
immers
viru
solut
electrospin
respect
specif
deliveri
dox
cell
achiev
conjug
fa
hcrsv
cmv
sparc
bind
peptid
peptid
receptor
ncadherin
target
rcnmv
well
util
cpmv
natur
interact
surfac
vimentin
instanc
dox
encapsul
within
hibiscu
chlorot
ringspot
viru
hcrsv
conjug
fa
effici
inhibit
ovarian
cancer
cell
growth
achiev
differ
drug
efficaci
observ
human
diploid
fibroblast
cell
test
control
normal
cell
figur
anoth
exampl
cpmv
use
treatment
hela
cell
display
dox
attach
either
direct
coval
bond
disulfid
linker
disulfid
linkag
cell
kill
similar
free
dox
like
due
releas
drug
cell
cultur
media
particl
uptak
coval
attach
dox
cpmv
result
effici
cell
kill
free
dox
almost
complet
elimin
cell
concentr
cpmv
formul
wherea
cell
treat
free
dox
still
complet
viabl
virusbas
platform
also
explor
codeliveri
therapi
one
studi
investig
feasibl
deliv
hygromycin
dox
specif
either
human
breast
adenocarcinoma
cell
overexpress
human
epidermoid
carcinoma
cell
overexpress
egfr
dox
deliveri
success
shown
requir
cathepsinb
cleavabl
peptid
linker
efficaci
deliveri
hygromycin
particularli
impress
improv
potenc
compar
free
drug
administr
howev
differ
target
strategi
use
make
difficult
draw
conclus
rel
efficaci
two
drug
anoth
studi
assess
rang
therapeut
cargo
could
encapsul
within
includ
doxorubicin
cisplatin
along
ricin
toxin
achain
rta
use
formul
bind
hepatocellular
carcinoma
hcc
cell
fold
higher
avid
compar
cell
type
encapsul
dox
individu
shown
effect
free
dox
encapsul
cocktail
compris
three
chemotherapeut
even
effect
ic
concentr
nm
deliveri
toxin
rta
also
remark
almost
complet
elimin
cell
concentr
fm
without
affect
viabil
control
cell
target
chemotherapeut
cocktail
highli
effect
approach
use
prodrug
also
investig
reduc
risk
toxic
exampl
instead
direct
deliveri
treatment
option
encapsul
enzym
yeast
cytosin
deaminas
ycd
altern
method
result
presenc
target
cell
convers
consequ
caus
target
cell
death
anoth
studi
util
convers
prodrug
deliveri
exogen
protein
horseradish
peroxidas
hrp
demonstr
display
peptid
select
prostat
cancer
cell
deliveri
hrp
abl
oxid
acid
produc
peroxyl
radic
led
cytotox
anticanc
drug
investig
virusbas
nanoparticl
deliveri
includ
taxol
bortezomib
btz
trastuzumab
herceptin
cardiovascular
diseas
anoth
rout
virusbas
therapeut
intervent
cpmv
deliveri
chromium
shown
promis
protect
diabet
atherosclerosi
vascular
smooth
muscl
cell
addit
filament
phage
appli
deliveri
antibacteri
agent
includ
neomycin
chloramphenicol
growth
inhibit
e
coli
aureu
streptococcu
pyogen
antivir
deliveri
viral
vector
new
develop
similar
tropism
plant
viru
cpmv
antigen
present
cell
commonli
subvert
pathogen
virus
exploit
combat
chronic
infecti
diseas
caus
prototyp
arenaviru
lymphocyt
choriomenig
viru
recent
drug
deliveri
vnp
vlp
demonstr
vivo
sinc
tmv
hollow
nanotub
neg
charg
interior
channel
could
taken
advantag
load
cation
drug
highli
potent
platinum
dnabind
drug
phenanthriplatin
introduc
within
carrier
shown
releas
acid
condit
tmv
deliveri
phenanthriplatin
appli
tripl
neg
breast
cancer
mous
xenograft
model
much
greater
efficaci
observ
tmvphenanthriplatin
compar
free
drug
clinic
use
cisplatin
control
smaller
tumor
growth
like
due
better
transport
drug
tumor
cell
nanocarri
combin
tmv
phenanthriplatin
show
potenti
bring
effect
new
chemotherapi
clinic
virusbas
nanoparticl
drug
deliveri
quickli
grow
field
expect
progress
toward
clinic
applic
also
fast
approach
tissu
engineeringvirus
incorpor
biocompat
tissu
engin
scaffold
direct
cell
growth
align
differenti
neighbor
environ
affect
behavior
cell
term
biolog
cue
presenc
chemokin
ligand
well
physic
cue
topolog
mechan
moduli
use
knowledg
scaffold
design
regul
cell
manner
suitabl
applic
repair
replac
damag
tissu
first
step
cell
adhes
viral
scaffold
investig
pioneer
work
util
layerbylay
lbl
assembl
cpmv
polym
poli
diallyldimethylammonium
chlorid
pdda
form
thin
film
found
aid
adhes
prolifer
fibroblast
layer
lead
cpmv
adsorpt
greater
cell
adhes
research
move
toward
use
filament
virus
better
mimic
structur
extracellular
matrix
ecm
coat
tmv
differ
cell
bind
motif
deriv
integrin
bind
matrix
protein
collagen
fibronectin
onto
high
bind
plate
demonstr
peptid
sequenc
display
play
role
cell
adhes
morpholog
cell
cultur
tmv
rgd
motif
form
filopodi
extens
adher
weakli
compar
cell
remain
round
cultur
tmv
display
collagen
mimet
sequenc
screen
influenc
variou
biochem
cue
cell
prolifer
morpholog
phagechip
construct
array
nanofib
label
variou
peptid
growth
factor
selfassembl
gold
chip
monitor
use
surfac
plasmon
reson
spr
spectroscopi
effect
cultur
cell
progress
toward
mimick
ecm
look
synthes
fibrou
matric
electrospin
rgdmodifi
virus
polym
nanofib
made
tmv
polyvinyl
alcohol
pva
poli
lacticcoglycol
acid
plga
form
biodegrad
fibrou
matric
enhanc
cell
adhes
prolifer
spread
babi
hamster
kidney
bhk
fibroblast
cell
respect
compar
scaffold
polym
alon
advanc
cell
adhes
prolifer
extern
stimulu
also
direct
orient
cell
growth
import
function
mani
cell
type
cardiac
skelet
myocyt
take
advantag
avail
virus
elong
geometri
tmv
util
cell
align
earli
studi
rgd
motif
selfassembl
parallel
arrang
slow
dri
drag
method
form
thin
film
orient
growth
chines
hamster
ovari
cho
cell
achiev
shear
method
produc
consist
result
investig
ecm
deposit
cell
cultur
film
reveal
correl
cellular
align
orient
fibronectin
collagen
deposit
fibroblast
produc
ecm
protein
result
tendenc
deviat
origin
pattern
thu
fibroblast
display
reduc
align
time
well
compar
less
ecmproduc
bhk
cell
method
align
viral
nanorod
subsequ
cell
includ
shear
forc
fluid
flow
glass
capillari
microcontact
print
combin
dipcoat
myogen
differenti
myoblast
cell
achiev
exposur
differenti
media
orient
cell
growth
addit
form
film
fabric
align
fiber
possibl
base
interfaci
polyion
complex
demonstr
inject
neg
charg
rgdlabel
phage
solut
cation
polym
pei
pll
chitosan
fibroblast
cell
encapsul
coinject
phage
solut
grew
well
within
fiber
seven
day
began
spread
along
matrix
within
phage
fiber
demonstr
potenti
viru
scaffold
cell
growth
remodel
tissu
cultur
also
form
treatment
cell
hydrogel
magnet
levit
cell
cluster
could
control
magnet
field
profil
magnet
use
hydrogel
fabric
simpl
combin
solut
gold
nanoparticl
display
rgd
addit
inclus
magnet
iron
oxid
nanoparticl
levit
cell
cultur
abl
recapitul
vivo
behavior
observ
similar
protein
express
pattern
well
infiltr
highli
invas
glioblastoma
cell
cocultur
astrocyt
applic
phage
nanofib
format
growth
differenti
neural
cell
fiber
contain
display
rgd
ikvav
laminin
motif
play
role
neural
cell
adhes
neurit
extens
shown
advantag
neural
progenitor
cell
npc
prolifer
differenti
extens
neurit
parallel
fiber
observ
cell
bind
motif
crucial
induc
neural
cell
growth
demonstr
use
control
rge
peptid
result
drastic
decreas
cell
adhes
neurit
outgrowth
rang
cell
bind
peptid
deriv
fibronectin
collagen
investig
found
effect
support
neural
growth
enhanc
neurit
extens
would
interest
studi
specif
interact
cell
scaffold
better
understand
role
peptid
cell
differenti
addit
cell
bind
motif
immobil
growth
factor
phage
demonstr
retain
bioactiv
bfgf
shown
promot
npc
prolifer
ngf
lead
greater
neural
differenti
furthermor
recent
studi
demonstr
electroact
could
also
use
augment
neural
tissu
regener
tmv
modifi
polyanilin
dope
poli
styrenesulfon
pss
align
flow
capillari
tube
shown
increas
percentag
cell
neurit
outgrowth
well
percentag
cell
bipolar
morpholog
viru
scaffold
limit
neural
differenti
far
extens
research
perform
osteogen
differenti
earli
studi
look
osteoblast
differenti
bone
marrow
stromal
cell
icosahedr
turnip
yellow
mosaic
viru
tymv
osteocalcin
gene
express
onset
miner
found
day
earlier
cell
grown
tymvcoat
substrat
compar
tissu
cultur
plastic
cultur
osteogen
media
indic
nanotopolog
impart
tymv
support
osteogen
differenti
similar
data
found
substrat
coat
rodshap
tmv
dna
microarray
data
show
differenti
express
larg
panel
gene
bone
morphogenet
protein
particular
found
especi
import
osteogen
differenti
manner
rapid
onset
gene
protein
express
enhanc
found
tmv
coat
substrat
ad
cell
media
verifi
role
nanotopolog
addit
conjug
phosphat
group
exterior
tmv
boost
differenti
aid
incorpor
calcium
consequ
highli
enrich
miner
ecm
relat
strategi
miner
util
genet
engin
display
highli
neg
charg
e
peptid
phage
could
selfassembl
nanofib
presenc
calcium
ion
led
hydroxyapatit
format
addit
phosphat
ion
effect
multival
present
variou
ligand
also
studi
rapid
differenti
nodul
format
observ
substrat
tmv
coat
rgd
day
serumfre
osteogen
media
found
tmv
genet
engin
display
rgd
tmv
chemic
conjug
rgd
also
enhanc
bone
differenti
absenc
osteogen
supplement
present
rgd
addit
synergi
peptid
phsrn
actual
found
suffici
induc
osteoblast
differenti
mesenchym
stem
cell
msc
display
dgea
peptid
deriv
collagen
along
pdpleprrevc
deriv
osteocalcin
ygfgg
deriv
osteogen
growth
peptid
also
shown
acceler
prolifer
differenti
msc
osteoblast
capabl
selfassembl
longrang
order
morpholog
use
dipcoat
method
form
nemat
orthogon
twist
cholester
helic
ribbon
smectic
helicolid
nanofila
base
condit
phage
concentr
pull
speed
film
form
use
rgd
eeee
peptidelabel
phage
could
use
control
soft
hard
tissu
format
smectic
hilcolid
nanofila
surfac
particular
demonstr
form
enamellik
composit
treat
calcium
phosphat
ion
move
toward
scaffold
tmvrgd
incorpor
within
porou
algin
hydrogel
resultantli
produc
greater
cell
attach
enhanc
osteogen
differenti
print
scaffold
compos
hydroxyapatit
phosphat
anoth
approach
introduct
combin
chitosan
within
scaffold
pore
led
osteogenesi
also
angiogenesi
inclus
vegf
enhanc
effect
figur
new
direct
area
incorpor
gene
deliveri
within
tissu
engin
construct
mutant
flagtag
aav
tether
scaffold
made
plga
gelatin
spong
antiflag
antibodi
viru
transduct
observ
hela
cell
seed
onto
scaffold
vitro
implant
vivo
nude
mice
furthermor
transduct
observ
cell
cultur
dropcast
film
consist
hybrid
phage
construct
combin
phage
aavderiv
gene
cassett
still
earli
stage
develop
tissu
regener
reprogram
cellular
defect
could
made
possibl
combin
tissu
engin
gene
deliveri
futur
translat
virusbas
tissu
scaffold
immunogen
longterm
effect
virus
must
consid
investig
vivo
behavior
implant
porou
algin
hydrogel
contain
tmv
tmvrgd
reveal
good
biocompat
evidenc
normal
wound
heal
hydrogel
biodegrad
time
patholog
inflamm
littl
immun
respons
trigger
oppos
intramuscular
inject
nativ
tmv
addit
degrad
hydrogel
expect
proteinbas
virus
also
degrad
time
cell
proteinas
thu
mitig
concern
implic
longterm
deposit
materi
sinc
previou
work
shown
viral
substrat
util
rapid
differenti
serumfre
media
thu
without
presenc
xenogen
protein
growth
factor
implant
tissu
scaffold
ex
vivo
cultur
cell
tangibl
realiti
realm
biotechnolog
virus
found
use
varieti
applic
includ
peptid
display
technolog
confin
synthesi
multiplex
sensor
diagnost
nanoreactor
catalyst
well
agricultur
sever
exampl
discuss
follow
section
first
technolog
cover
phage
display
routin
appli
myriad
applic
display
foreign
sequenc
filament
phage
first
describ
georg
smith
sinc
becom
promin
method
select
peptid
antibodi
affin
specif
target
encompass
organ
inorgan
matter
mani
review
written
delv
depth
phage
display
technolog
aim
section
discuss
characterist
phage
display
highlight
interest
studi
latest
applic
base
origin
research
phage
studi
e
coli
filament
bacteriophag
includ
fd
common
platform
util
phage
display
gener
structur
filament
phage
shown
figur
illustr
phage
compris
number
minor
major
coat
protein
piii
pviii
protein
usual
util
display
foreign
protein
like
due
greater
access
tip
side
respect
display
pvi
pvii
pix
also
success
implement
brief
phage
display
util
genet
program
phage
coat
protein
insert
random
sequenc
dna
within
protein
gene
use
form
librari
phage
billion
differ
foreign
peptid
protein
present
sever
round
pan
amplif
isol
specif
phage
bind
target
ident
bind
peptid
protein
display
determin
sequenc
wherea
insert
pviii
limit
around
cyclic
phage
librari
librari
display
sequenc
random
residu
piii
possibl
phage
display
limit
filament
phage
librari
base
phage
lambda
also
possibl
anoth
altern
proven
use
phage
display
use
phagemid
phagemid
typic
contain
tradit
plasmid
aspect
plasmid
replic
origin
restrict
enzym
recognit
site
antibiot
select
marker
well
phage
aspect
includ
phage
origin
replic
gene
piii
fuse
protein
interest
figur
coinfect
helper
phage
suppli
structur
protein
requir
phage
format
complet
virion
assembl
around
phagemid
dna
recov
advantag
use
phagemid
includ
eas
clone
recombin
effici
transform
smaller
genom
incorpor
larger
foreign
gene
greater
genet
stabil
multipl
round
propag
phage
phagemid
display
technolog
given
rise
numer
opportun
isol
proteinbas
ligand
rang
applic
simplest
form
screen
perform
vitro
target
interest
immobil
solid
support
use
techniqu
peptid
identifi
specif
target
includ
inorgan
materi
hydroxyapatit
silver
quantum
dot
well
organ
materi
microtubul
fibrin
integrin
exampl
bind
peptid
use
biominer
format
hard
tissu
well
nucleat
growth
pattern
metal
note
mani
exampl
found
section
involv
miner
reli
use
metal
bind
peptid
nucleat
addit
peptid
select
bind
also
obstruct
function
target
demonstr
peptid
identifi
inhibit
proteas
human
neutrophil
elastas
well
cancerassoci
matrix
metalloproteinas
versatil
technolog
expand
beyond
peptid
identif
exampl
phage
librari
design
display
fab
antigenbind
fragment
scfv
implic
identif
antibodi
bioassay
well
immunotherapi
exampl
includ
construct
fab
phage
display
librari
isol
antibodi
specif
human
prostat
cancer
cell
gener
identif
scfv
antibodi
recogn
marker
angiogenesi
besid
fab
scfv
altern
method
display
antibodi
heavyand
lightchain
variabl
region
separ
display
pvii
pix
respect
demonstr
effect
drive
format
function
fv
heterodim
may
greater
affin
stabil
compar
scfv
enzym
substrat
also
display
phage
either
independ
togeth
singl
particl
order
screen
function
enzym
catalyst
copresent
enzym
substrat
achiev
use
interven
linker
two
activ
enzym
select
pan
product
format
asid
immobil
isol
target
surfac
select
method
also
demonstr
cultur
cell
well
ex
vivo
vivo
select
cell
bind
peptid
use
pan
cell
line
variou
type
fibroblast
myoblast
peptid
high
cellular
specif
identifi
manner
peptid
isol
specif
endotheli
cell
associ
atherosclerosi
breast
cancer
cell
hepatocellular
carcinoma
cell
melanoma
cell
ovarian
cell
among
other
ex
vivo
pan
work
similarli
except
librari
screen
cell
tumor
mass
isol
bind
peptid
identifi
rang
cell
type
includ
neuroblastoma
cell
islet
cell
colon
adenoma
cell
vivo
phage
display
particularli
noteworthi
lend
mani
differ
applic
exampl
peptid
target
specif
organ
examin
use
vivo
screen
random
peptid
mous
model
multipl
round
phage
administr
isol
amplif
peptid
local
brain
kidney
identifi
furthermor
attach
brain
target
peptid
fix
red
blood
cell
result
accumul
cell
brain
greater
extent
kidney
anoth
investig
also
studi
kidney
target
vivo
found
peptid
specif
could
use
tailor
pharmacokinet
direct
clearanc
toward
kidney
away
reticuloendotheli
system
rapid
clearanc
could
achiev
vivo
screen
also
appli
human
map
uniqu
zip
code
line
vasculatur
uniqu
tripeptid
motif
specif
variou
region
around
bodi
identifi
biopsi
bone
marrow
fat
tissu
skelet
muscl
prostat
skin
liver
perform
could
util
toward
creation
map
molecular
signatur
along
human
vasculatur
exampl
indic
reach
phage
display
applic
extens
encompass
miner
vitro
assay
target
deliveri
molecular
imag
vaccin
tissu
engin
multival
virus
appli
sens
multiplex
system
high
degre
multival
shown
improv
detect
limit
number
set
phage
identifi
librari
desir
target
sequenc
directli
appli
sensor
genet
engin
simplifi
manufactur
larg
quantiti
phage
display
specif
target
moieti
sever
review
cover
wide
rang
sens
applic
avail
materi
besid
phage
mani
virusbas
platform
technolog
also
develop
signal
detect
amplif
exampl
cover
broad
rang
virusbas
materi
incorpor
manifold
sens
technolog
includ
antibodybas
electrochem
optic
techniqu
enzymelink
immunosorb
assay
elisa
tradit
techniqu
detect
target
antigen
although
sever
variat
exist
gener
reli
three
compon
probe
specif
target
antibodi
tag
enzym
detect
probe
substrat
convert
presenc
enzym
first
probe
tend
also
antibodi
specif
target
phage
display
introduc
opportun
use
peptid
target
recognit
exampl
phage
decor
peptid
isol
phage
display
use
elisa
detect
anthrax
spore
surfac
antigen
hbv
altern
present
peptid
virus
antibodi
also
present
viral
scaffold
multival
detect
previou
section
discuss
phage
display
genet
engin
could
use
display
antibodi
fragment
thereof
anoth
approach
recent
demonstr
function
pvxbase
nanoparticl
protein
fragment
use
display
whole
antibodi
molecul
use
protein
properti
bind
fc
region
heavi
chain
igg
pvx
particl
could
use
plugandplay
system
display
varieti
antibodi
level
orient
control
achiev
chemic
conjug
instead
sampl
immobil
follow
probe
antigen
sampl
virusbas
detector
virus
display
antigen
could
first
immobil
incub
sampl
detect
presenc
certain
antibodi
demonstr
success
approach
diagnosi
primari
syndrom
psj
chronic
system
autoimmun
diseas
whose
heterogen
often
delay
diagnosi
lipo
peptid
deriv
human
autoantigen
lipocalin
display
pvx
nanoparticl
platform
shown
specif
psj
patient
sera
greater
reactiv
peptid
alon
hand
ecpmvbas
display
lipo
reactiv
like
due
smaller
densiti
peptid
display
regardless
pvx
elisa
promis
futur
implement
addit
benefit
found
stabil
coat
loss
specif
sensit
observ
even
two
month
storag
anoth
aspect
elisa
enzym
use
quantif
via
substrat
convers
hrp
popular
enzym
elisa
due
abil
convert
chromogen
substrat
color
product
chemiluminesc
substrat
fluoresc
product
immobil
hrp
well
glucos
oxidas
gox
explor
use
cpmv
tmv
platform
addit
sens
molecul
virion
requir
use
elisa
display
enzym
particl
directli
use
sens
gox
catalyz
oxid
glucos
concurr
gener
hydrogen
peroxid
reduc
water
hrp
presenc
substrat
therefor
two
enzym
coupl
form
glucos
sens
system
hrp
substrat
convers
use
detect
fact
tmv
nanorod
result
higher
substrat
convers
rate
control
sampl
input
enzym
could
due
combin
greater
surfac
area
better
steric
access
present
enzym
one
exampl
potenti
enzymebas
sensor
immobil
enzym
catalyz
reaction
could
also
consid
creation
sensit
biosensor
output
immunosorb
assay
need
enzymelink
altern
readout
option
includ
fluoresc
particl
exampl
phage
isol
pan
staphylococc
enterotoxin
b
seb
agent
caus
food
poison
label
fluorophor
use
probe
seb
base
fluoresc
read
seb
detect
concentr
ngwell
anoth
exampl
dyelabel
cpmv
conjug
antibodi
use
detect
seb
botulinum
toxin
bacterium
campylobact
jejuni
detect
seb
specif
quantifi
limit
detect
improv
cpmv
formul
compar
mole
equival
dyelabel
antibodi
fluoresc
use
sens
function
found
applic
fluoresc
label
cpmv
dna
microarray
sensor
addit
coupl
neutravidin
capsid
cpmv
could
use
detect
reagent
one
result
investig
demonstr
deliveri
multipl
dye
use
cpmv
result
signal
amplif
led
detect
gene
compar
control
rat
express
array
figur
anoth
fluoresc
sens
applic
util
lbl
assembl
label
quantum
dot
along
quencher
display
explos
tnt
design
film
allow
highli
select
detect
tnt
sub
ppb
level
evolut
fluoresc
signal
quencher
displac
optic
sensor
also
encompass
util
spr
detect
exampl
lbl
assembl
cation
anion
gold
nanoparticl
result
develop
spr
spectrum
sensit
humid
therefor
possibl
util
electrostat
assembl
integr
virus
humid
sens
devic
spr
also
appli
sensor
immunoassay
exemplifi
detect
foodborn
bacterium
listeria
monocytogen
use
gold
spr
sensor
chip
display
scfv
antibodi
recogn
l
monocytogen
cell
immobil
sensor
chip
inject
sampl
measur
chang
reson
due
bind
cell
allow
specif
detect
level
around
cfuml
surfac
enhanc
raman
spectroscopi
ser
anoth
approach
consid
sens
reli
signal
enhanc
raman
signal
close
proxim
surfac
nobl
metal
due
sensit
techniqu
uniqu
signatur
variou
report
ser
promis
techniqu
multiplex
analysi
phage
select
phage
display
bind
model
rabbit
antigoat
igg
antigen
label
raman
report
conjug
au
ag
coreshel
nanoparticl
due
high
surfac
area
report
present
result
construct
impart
exponenti
increas
raman
intens
observ
compar
similarli
label
antibodi
model
antigen
also
appli
colorimetr
sensor
base
chang
modul
selfassembl
structur
applic
discuss
detail
section
besid
optic
sens
virus
also
found
applic
electrochem
sens
three
differ
exampl
highlight
involv
electrochem
imped
spectroscopi
amperometri
measur
first
exampl
gold
electrod
surfac
monolay
attach
use
detect
antibodi
well
prostatespecif
membran
antigen
psma
marker
prostat
cancer
resist
compon
imped
z
measur
khz
increas
upon
analyt
bind
measur
characterist
could
use
highli
specif
detect
concentr
around
nm
next
exampl
thin
film
tmv
conjug
electroact
oligoanilin
use
detect
volatil
organ
compound
specif
methanol
ethanol
respons
current
measur
thin
film
sensor
high
respons
observ
presenc
ethanol
methanol
observ
acetonitril
isobutyl
alcohol
tetrahydrofuran
toluen
aceton
moreov
current
measur
exhibit
reproduc
well
quick
respons
time
absorpt
desorpt
compound
final
last
exampl
involv
applic
solut
tmv
display
bind
peptid
tnt
insolut
sens
molecul
result
bind
tnt
tmv
diffus
coeffici
tnt
reduc
differenti
farada
current
signatur
electroact
compound
caus
differenti
current
proport
tnt
concentr
therefor
could
use
tnt
sens
detect
use
method
limit
tnt
expand
rel
small
electroact
speci
sens
approach
wide
appli
diseas
diagnost
involv
use
assay
detect
amplifi
nucleic
acid
content
infecti
agent
bacteria
virus
qualiti
control
import
consider
ensur
result
assay
accur
exampl
failur
wellknown
polymeras
chain
reaction
pcr
assay
could
occur
due
nucleic
acid
degrad
presenc
inhibitor
bile
salt
polysaccharid
clinic
sampl
could
potenti
lead
reduct
polymeras
bind
activ
fals
neg
due
failur
process
may
monitor
incorpor
known
rna
dna
sampl
serv
posit
intern
control
verifi
nucleic
acid
degrad
occur
process
end
viral
capsid
found
util
due
abil
shield
nucleic
acid
nucleas
digest
serv
better
mimic
use
viral
assay
allow
longterm
storag
control
design
socal
armor
rna
develop
patent
asuragen
cenetron
diagnost
first
develop
function
wellcharacter
control
resist
rnase
armor
rna
compris
rna
standard
sequenc
encapsul
within
capsid
coproduc
use
express
vector
e
coli
figur
desir
rna
within
particl
subsequ
releas
heat
minut
pioneer
studi
control
test
hiv
revers
transcriptionpcr
rtpcr
assay
use
noninfecti
consensu
sequenc
taken
gag
gene
armor
rna
particl
found
stabl
anticoagul
plasma
loss
signal
storag
varieti
condit
month
month
even
five
freezethaw
cycl
sinc
initi
result
armor
rna
appli
control
vast
array
assay
includ
detect
hcv
respiratori
virus
influenza
sever
acut
respiratori
syndrom
sar
virus
enterovirus
west
nile
viru
even
util
surrog
viru
detect
anim
pathogen
includ
classic
swine
fever
viru
csfv
fmdv
vesicular
stomat
viru
vsv
sever
develop
technolog
made
enhanc
util
armor
rna
origin
area
hiv
detect
armor
rna
expand
beyond
rtpcr
assay
branch
dna
bdna
assay
provid
reliabl
method
quantif
rna
requir
longer
kb
rna
control
standard
strategi
rna
encapsul
within
limit
around
kb
increas
packag
effici
overcom
limit
achiev
incorpor
translat
repressor
stemloop
within
rna
specif
interact
capsid
trigger
selfassembl
viral
shell
around
cargo
manner
armor
rna
contain
longer
hiv
pol
gene
success
synthes
perform
reliabl
standard
bdna
assay
hcv
armor
rna
also
develop
rtpcr
bdna
assay
addit
work
demonstr
applic
genotyp
assay
well
allow
distinct
specif
subtyp
hcv
realtim
rtpcr
reaction
fals
neg
could
occur
singleplex
primerprob
assay
use
sinc
mismatch
set
primer
could
exist
number
sampl
thu
dualspecif
rna
control
duplex
assay
test
result
enhanc
sensit
detect
found
compar
monospecif
assay
beyond
control
detect
singl
viru
type
armor
rna
chimera
also
creat
one
studi
chimer
rna
sequenc
deriv
mix
gene
fragment
hcv
sar
coronaviru
sar
coronaviru
abl
packag
fairli
larg
kb
rna
sequenc
within
demonstr
versatil
control
multipl
differ
rtpcr
assay
detect
individu
viru
anoth
studi
rna
fragment
influenza
influenza
b
sar
virus
splice
togeth
one
fragment
order
creat
singl
control
simultan
test
common
respiratori
virus
may
result
similar
clinic
symptom
use
multiplex
rtpcr
three
virus
differ
report
dye
simultan
amplif
detect
could
achiev
highli
sensit
detect
limit
armor
rna
virus
natur
extens
armor
rna
technolog
encapsul
dna
within
bacteriophag
capsid
qualiti
control
dna
virus
earli
work
area
util
lambda
filament
fd
phage
dna
packag
greater
stabil
dna
observ
contain
control
dsdna
within
lambda
phage
confer
resist
dnase
digest
reliabl
amplif
pcr
assay
hbv
cytomegaloviru
store
sm
buffer
protect
dna
stabl
least
month
stabil
day
plasma
room
temperatur
could
achiev
may
result
greater
suscept
lambda
plasma
proteas
compar
ssdna
encapsul
fd
phage
demonstr
dna
taken
parvoviru
result
control
resist
nucleas
degrad
perform
similarli
nativ
viru
pcr
assay
similar
growth
curv
observ
furthermor
construct
remain
stabl
dilut
human
plasma
period
least
week
recent
return
armor
rna
root
taken
demonstr
encapsul
dsdna
result
extra
stabil
lambda
found
fd
phage
without
limit
ssdna
conjug
sulfhydrylmodifi
dna
sequenc
interest
aminemodifi
stemloop
dna
structur
assembl
dissoci
cp
could
trigger
around
stemloop
form
armor
dna
use
strategi
format
capsid
packag
hbv
hpv
dna
sequenc
length
rang
kb
accomplish
astonish
given
genom
kb
armor
dna
control
perform
well
pcr
genotyp
assay
storag
newborn
calf
serum
even
month
shown
affect
perform
encapsul
control
limit
bacteriophag
exampl
recombin
rna
particl
base
cpmv
also
util
intern
control
rtpcr
assay
produc
particl
cdna
clone
engin
contain
sequenc
desir
control
rna
alongsid
cpmv
code
coat
movement
protein
proofofconcept
studi
two
sequenc
fmdv
one
swine
vesicular
diseas
viru
svdv
clone
togeth
cassett
use
agroinfiltr
cowpea
plant
combin
plasmid
along
anoth
plasmid
cpmv
respons
replic
proteolyt
process
recombin
cpmv
particl
propag
recov
host
plant
cpmv
compon
contain
separ
compon
use
nycodenz
densiti
gradient
result
noninfecti
construct
due
relianc
replic
particl
perform
well
posit
control
detect
fmdv
svdv
addit
resist
rnase
perform
reliabl
even
day
storag
suspens
bovin
epithelium
room
temperatur
method
may
provid
low
cost
altern
armor
rna
maintain
advantag
stabil
rapid
product
anoth
altern
util
tmv
coat
protein
assembl
posit
control
helic
symmetri
result
particl
realist
mimick
stabil
filament
virus
approach
recent
demonstr
rtpcr
detect
ebov
construct
ebovtmv
mimic
purifi
cp
tmv
reassembl
around
rna
transcript
contain
ebov
sequenc
fragment
shorten
tmv
sequenc
contain
origin
assembl
oa
necessari
tmv
assembl
figur
ebov
sequenc
taken
region
rnadepend
rna
polymeras
gene
lgene
show
homolog
publish
ebov
sequenc
detect
ebov
tmv
sequenc
accomplish
use
multiplex
rtpcr
ebovtmv
particl
asid
ebov
primer
bind
site
ebov
sequenc
scrambl
therefor
pose
threat
infect
overal
ebovtmv
scalabl
construct
could
easili
adapt
control
ebov
diagnost
technolog
could
appli
mimick
filament
virus
one
first
demonstr
util
use
virus
display
biocatalyst
base
genet
engin
pvx
display
lipas
enzym
although
catalyt
activ
bound
enzym
lower
free
enzym
studi
demonstr
potenti
gener
catalyt
activ
nanoparticl
selfassembl
easili
propag
sinc
interest
function
viru
particl
enzym
grown
coupl
abil
viral
capsid
selfassembl
around
divers
rang
cargo
rather
simpli
nucleic
acid
encapsul
enzym
form
nanoreactor
becom
increas
relev
biotechnolog
initi
work
format
nanoreactor
look
incorpor
singl
enzym
within
capsid
disassembl
reassembl
capsid
hrp
encapsul
within
ccmv
result
estim
one
everi
capsid
contain
enzym
allow
studi
enzym
singlemolecul
level
comparison
activ
encapsul
nonencapsul
enzym
show
differ
signatur
due
time
necessari
dihydrorhodamin
substrat
diffus
fluoresc
rhodamin
product
diffus
capsid
resultantli
product
accumul
delay
loss
fluoresc
observ
spatial
constrain
hrp
investig
confin
enzym
pseudozyma
antartica
lipas
b
palb
within
ccmv
util
heterodimer
coiledcoil
linker
first
attach
palb
cp
subunit
assembl
vari
ratio
cp
without
palb
assembl
averag
number
encapsul
enzym
could
control
encapsul
palb
higher
activ
compar
nonencapsul
palb
hypothes
due
higher
enzym
concentr
consid
capsid
alon
addit
effect
reaction
veloc
vari
number
encapsul
enzym
one
four
palb
per
capsid
like
due
presenc
gener
one
substrat
molecul
per
capsid
make
one
enzym
unnecessari
substrat
convers
tether
encapsul
also
explor
use
rna
aptam
techniqu
util
coexpress
cp
revtag
peptidas
e
pepe
firefli
luciferas
bifunct
mrna
contain
aptam
genom
packag
hairpin
two
end
encapsul
enzym
express
assembl
strategi
result
enzym
encapsul
within
particl
enzym
remain
activ
encapsul
capsid
found
offer
protect
thermal
degrad
proteas
digest
well
hydrophob
adsorpt
onepot
expressionassembl
approach
also
util
enzym
tether
within
initi
studi
investig
program
encapsul
alcohol
dehydrogenas
adhd
homotetramer
enzym
celb
use
plasmid
harbor
gene
cp
scaffold
protein
sp
fuse
enzym
interest
sp
associ
interior
capsid
way
enzym
consequ
encapsul
express
assembl
protein
e
coli
adhd
encapsul
less
activ
due
enzym
crowd
effect
overal
similar
catalyt
effici
exhibit
substrat
inhibit
unlik
free
adhd
encapsul
celb
activ
tetramer
form
incorpor
multimer
enzym
demonstr
surprisingli
unlik
adhd
encapsul
celb
result
loss
activ
chang
substrat
affin
addit
embed
encapsul
celb
acrylamid
gel
dehydr
rehydr
gel
result
retent
activ
could
attribut
substrat
diffus
limit
therefor
present
util
nanoreactor
enzym
immobil
applic
consider
use
capsid
nanoreactor
influenc
electrostat
substrat
diffus
carrier
cp
assembl
around
neg
charg
alkalin
phosphatas
phoaneg
effect
capsid
mutat
ad
either
neg
posit
charg
around
pore
explor
unexpectedli
introduct
neg
charg
inhibitori
effect
addit
posit
charg
result
greater
catalysi
neg
charg
phosphatas
substrat
therefor
engin
nanoreactor
use
control
flux
extent
reaction
anoth
benefit
nanoreactor
also
seen
pepe
bestow
stabil
addit
exampl
encapsul
within
phosphotriesteras
low
heat
toler
prone
hydrolysi
yield
protect
proteas
desicc
well
thermal
stabil
activ
even
make
practic
option
enzym
combat
variou
harm
insecticid
nerv
agent
strategi
sequestr
enzym
within
express
also
valuabl
recoveri
otherwis
insolubl
protein
recombin
protein
traffick
inclus
bodi
product
e
coli
make
recoveri
difficult
gala
one
protein
studi
encapsul
within
shown
allow
success
rescu
properli
fold
gala
encapsul
result
highli
activ
enzym
hypothes
like
due
correctli
fold
activ
enzym
produc
manner
rang
applic
consid
nanoreactor
mani
demonstr
use
viral
scaffold
exampl
determin
immobil
cytochrom
insid
could
use
stabil
deliveri
human
cervix
carcinoma
cell
retent
substrat
convers
activ
could
exploit
enzymat
prodrug
therapi
addit
encapsul
nadh
oxidas
predominantli
reduc
oxygen
hydrogen
peroxid
demonstr
method
bacteri
growth
inhibit
trigger
oxid
damag
e
coli
cultur
notabl
recent
breakthrough
nanoreactor
technolog
use
catalysi
hydrogen
product
sequestr
oxygentoler
nickeliron
nife
hydrogenas
provid
greater
stabil
hydrogenas
resultantli
greater
increas
proton
reduct
activ
free
enzym
observ
scalabl
product
encapsul
hydrogenas
simpl
ferment
cheap
sustain
clean
fuel
product
realiz
develop
viral
nanoreactor
also
explor
introduct
multipl
enzym
tether
close
proxim
enzym
involv
cascad
product
one
enzym
effici
taken
input
next
assess
enzym
cascad
encapsul
evalu
tetramer
celb
monomer
atpdepend
galactokinas
galk
dimer
adpdepend
glucokinas
gluk
process
lactos
galactos
glucos
phosphoryl
galactos
form
phosphoryl
glucos
respect
figur
use
multienzym
glukcelbsp
galkglukcelbsp
fusion
coencapsul
twoand
threeenzym
cascad
within
achiev
compar
mixtur
individu
encapsul
control
show
greater
enzymat
convers
inhibitori
condit
celb
addit
show
greater
faster
turnov
rate
suggest
three
protein
assembl
properti
activ
form
success
encapsul
therefor
enzym
assembl
import
facilit
construct
complex
metabol
system
interest
area
recent
consid
applic
plant
virus
agricultur
sinc
natur
host
infect
plant
first
glanc
appear
counterintuit
appli
nanoparticl
particular
applic
howev
pioneer
studi
util
rcnmv
combat
parasit
root
nematod
infect
demonstr
particl
better
mobil
soil
therefor
improv
bioavail
abamectin
pesticid
nematod
control
use
ligand
gate
infus
see
section
neutral
charg
pesticid
could
load
within
rcnmv
manner
abamectin
cargo
protect
oxid
releas
time
encapsul
free
abamectin
show
similar
efficaci
liquid
nematod
cultur
test
infect
tomato
seedl
viral
deliveri
abamectin
result
healthier
root
growth
reduc
root
gall
compar
abamectin
alon
result
import
implic
agricultur
industri
parasit
nematod
result
astronom
cost
order
billion
worldwid
due
crop
damag
futur
consider
noninfecti
vlp
could
refin
strategi
use
natur
evolv
mechan
virus
cargo
deliveri
plant
plantbas
pharmaceut
productionin
section
discuss
glaxosmithklin
merck
medicago
inc
mapp
biopharmaceut
adopt
express
system
deriv
virus
product
vlp
vaccin
antibodi
cocktail
plant
use
medicago
inc
mapp
biopharmaceut
well
known
express
recombin
protein
wide
use
e
coli
yeast
express
system
focu
exampl
plantbas
product
system
section
illustr
advantag
util
plant
product
platform
undergon
rapid
growth
costeffect
highli
scalabl
safe
product
protein
pharmaceut
posttransl
modif
achiev
use
plant
viral
vector
due
advantag
cost
product
plant
system
offer
potenti
rapid
pharmaceut
develop
especi
impoverish
area
one
first
exampl
transfect
plant
viral
vector
demonstr
rapid
product
protein
relev
pharmaceut
util
express
vector
base
tmv
high
level
heterolog
express
biolog
activ
inhibit
hiv
replic
vitro
achiev
insert
gene
tmv
plasmid
control
transcript
use
subgenom
promot
regul
express
specif
gene
could
achiev
research
n
benthamianabas
express
system
found
suppress
posttranscript
gene
silenc
ptg
plant
adapt
immun
system
result
enhanc
effici
possibl
coexpress
protein
tomato
bushi
stunt
viru
tbsv
parallel
develop
magnicon
deconstruct
tmv
vector
system
result
advanc
product
capac
without
need
ptg
suppress
magnicon
system
involv
engin
dna
modul
replic
gene
interest
recombin
advantag
easili
modifi
use
gateway
technolog
univers
system
clone
modul
deliv
plant
agrobacterium
result
transient
gene
express
product
viral
rna
replicon
replic
autonom
furthermor
magnifect
weak
vacuum
infiltr
plant
immers
agrobacterium
suspens
transfect
larg
scale
quickli
achiev
without
need
cp
gene
wait
system
plant
movement
larg
varieti
biolog
relev
pharmaceut
produc
use
magnicon
includ
vlp
vaccin
antibodi
plagu
antigen
cytokin
growth
hormon
tmv
rnabas
overexpress
trbo
vector
anoth
replicon
system
develop
shown
promis
highlevel
protein
express
greater
yield
demonstr
aforement
transient
express
figur
essenti
trbo
vector
promoterdriven
tmv
express
vector
cp
gene
remov
cp
delet
result
higher
effici
recombin
protein
express
demonstr
rang
protein
includ
gfp
adenosin
kinas
th
domain
human
fibronectin
proteinas
anoth
studi
also
demonstr
use
trbo
vector
product
chimer
allergen
deriv
dust
mite
could
appli
asthma
diagnosi
immunotherapi
similar
express
system
deriv
plasmid
base
pvx
potexvirus
complet
pvx
construct
use
express
recombin
protein
alongsid
pvx
cp
insert
intern
ribosom
entri
site
allow
initi
translat
middl
mrna
two
gene
similar
construct
instead
interven
fmdv
cleavag
sequenc
use
creat
protein
express
fusion
cp
larger
insert
tend
result
genet
instabl
loss
gene
interest
combin
introduc
heterolog
subgenom
promot
bamboo
mosaic
viru
delet
portion
nterminu
cp
found
success
strategi
increas
transgen
express
stabil
deconstruct
vector
also
use
pvxbase
express
system
exampl
replac
cp
gene
tripl
gene
block
tgb
encod
movement
protein
effici
product
gene
insert
achiev
suppress
ptg
help
improv
yield
transient
coexpress
tbsv
hcpro
tobacco
etch
viru
tev
result
increas
gene
express
respect
ampliconplu
target
technolog
util
benefit
gene
silenc
suppress
enhanc
product
technolog
involv
use
transgen
tevb
tobacco
line
express
suppressor
gene
infect
pvx
amplicon
contain
gene
interest
success
product
highli
labil
vaccin
protein
canin
oral
papillomaviru
achiev
system
use
express
recombin
protein
fuse
chloroplast
target
peptid
coupl
pvx
tmv
viral
vector
system
also
evalu
demonstr
use
approach
resolv
complic
competit
multipl
replicon
cell
noncompetit
viral
system
express
assembl
oligomer
protein
accomplish
construct
fulllength
igg
heavi
light
chain
exampl
potexviru
vector
includ
vector
base
plantago
asiatica
mosaic
viru
plamv
foxtail
mosaic
viru
fomv
recombin
plamv
vector
found
greater
genet
stabil
longer
retent
insert
gene
compar
pvx
like
due
stronger
rna
silenc
suppress
activ
found
first
movement
protein
tgb
hand
fomvbas
fect
vector
seri
util
deconstruct
plasmid
cp
tgb
delet
requir
coexpress
suppressor
ptg
move
system
cpmvbase
express
system
also
shown
great
versatil
enhanc
express
larg
rang
protein
includ
antibodi
human
gastric
lipas
vlp
vaccin
btv
vlp
discuss
section
cpmv
bipartit
viru
provid
replic
protein
process
capabl
code
movement
coat
protein
alter
shorter
remov
movement
coat
protein
append
gene
interest
express
foreign
gene
achiev
inocul
plant
construct
modifi
agroinfiltr
construct
tbsv
suppressor
silenc
found
overcom
necess
addit
elimin
second
start
codon
untransl
region
utr
locat
posit
result
hypertransl
downstream
protein
like
due
aug
inhibitori
overal
translat
discoveri
high
protein
express
could
achiev
without
restrict
insert
size
without
need
rnadepend
rna
polymeras
hypertranslat
cpmv
cpmvht
system
describ
packag
peaq
express
vector
easi
recombin
gene
interest
insert
modifi
utr
utr
express
plasmid
peaq
vector
broad
applic
perhap
one
greatest
advantag
product
vlp
vaccin
medicago
inc
use
cpmvht
largescal
product
envelop
influenza
vlp
observ
bud
plasma
membran
result
envelop
similar
structur
characterist
influenza
viral
particl
ecpmv
also
produc
use
peaq
system
necessari
protein
cpmv
format
name
cp
precursor
proteinas
could
either
express
vector
two
cpmvht
vector
form
matur
ecpmv
particl
devoid
nucleic
acid
encapsul
sinc
peaq
vector
nonrepl
level
express
multipl
protein
control
coinfiltr
appropri
concentr
express
vector
manner
complex
vlp
btv
vlp
consist
four
differ
protein
assembl
last
exampl
plant
viral
express
vector
come
geminivirus
small
ssdna
virus
twin
capsid
morpholog
inplant
activ
inpact
express
platform
notabl
use
splitgen
cassett
stabli
transform
plant
inpact
cassett
base
deconstruct
tobacco
yellow
dwarf
viru
tydv
genom
consist
two
compon
gene
interest
split
two
exon
flank
larg
intergen
region
lir
small
intergen
region
sir
rep
repa
activ
gene
requir
replic
activ
recombin
protein
product
induc
ethanol
bind
rep
site
within
lir
initi
roll
circl
replic
replicon
system
ethanol
induct
protein
product
separ
plant
growth
allow
high
level
protein
express
could
cytotox
inhibit
plant
develop
anoth
method
use
singlevector
dna
replicon
system
base
bean
yellow
dwarf
viru
beydv
exemplifi
product
oligomer
monoclon
antibodi
protect
ebov
plasmid
contain
two
tandemli
link
replicon
heavi
light
chain
requir
sir
lir
reprepa
viral
compon
system
result
noncompet
replicon
amplif
protein
express
effici
assembl
igg
tetram
final
exampl
pric
similar
beydvderiv
autonom
replic
vector
present
advanc
previou
high
express
nonrepl
ptrac
cassett
pric
replicon
gene
vector
creat
addit
sir
lir
reprepa
gene
result
gene
amplif
order
magnitud
greater
product
major
cp
subunit
vaccin
antigen
compar
ptrac
clearli
mani
option
quick
high
yield
recombin
protein
product
plant
although
magnicon
use
wide
past
util
multipl
modul
like
detract
effici
develop
system
use
singl
construct
may
lead
greater
popular
main
applic
plantbas
product
antibodi
vaccin
product
pharmaceut
protein
type
also
produc
techniqu
design
develop
devic
nanoscal
featur
open
door
novel
effici
way
captur
store
transfer
energi
sinc
virus
selfassembl
coat
protein
nanoscal
structur
proteinbas
build
block
also
show
inher
propens
selfassembl
higherord
hierarch
assembl
provid
ideal
build
scaffold
design
nanostructur
materi
versatil
hybrid
virusbas
materi
energi
scienc
applic
alreadi
recogn
exampl
highlight
follow
section
function
virusbas
materi
yield
energyrelev
materi
light
harvest
system
plasmon
metamateri
energi
data
storag
system
hurdl
product
mesoscal
nanostructur
materi
avail
highprecis
manufactur
technolog
facilit
largescal
assembl
also
provid
spatial
control
nanomet
level
topdown
approach
deriv
technolog
implement
comput
industri
progress
provid
tighter
control
featur
dimens
impecc
reproduc
program
featur
compon
reli
lithograph
fabric
photolithographi
microcontact
print
soft
lithographi
block
copolym
nanolithographi
nanoimprint
lithographi
scanningprob
dippen
lithographi
although
topdown
approach
facilit
extraordinari
reproduc
write
nanoscal
featur
centimet
size
scale
technolog
highli
special
featur
size
still
limit
hand
bottomup
approach
seek
achiev
direct
control
assembl
individu
compon
hierarch
architectur
close
mimic
biolog
system
cell
organ
orchestr
complex
energi
convers
function
develop
art
scienc
selfassembl
made
tremend
contribut
organ
composit
materi
render
high
precis
manufactur
energyrelev
biomolecular
inorgan
materi
possibl
exampl
dnabas
program
exploit
sequencespecif
base
pair
precis
posit
materi
space
chemic
program
hierarch
structur
also
devis
seen
synthesi
branch
dendrim
system
method
includ
use
synthet
block
copolym
applic
orthogon
pair
coiledcoil
peptid
induc
selfassembl
nanoparticl
clear
selfassembl
hold
great
potenti
nanomanufactur
mesoscal
materi
simpl
solutionbas
bottomup
synthesi
virusbas
selfassembl
one
approach
present
sever
uniqu
advantag
exampl
high
aspect
ratio
viru
particl
plant
viru
tmv
bacteriophag
form
excel
biologyderiv
scaffold
templat
synthesi
inorgan
matter
produc
nanowir
mesoscal
case
tmv
miner
achiev
interior
channel
around
exterior
surfac
lead
explicit
control
width
wire
coupl
viral
particl
miner
techniqu
semiconduct
superconduct
insul
nanowir
form
result
hybrid
materi
properti
interest
energi
scienc
electron
industri
highord
assembl
bridg
nanotomesoscal
also
achiev
selfassembl
instanc
tmv
build
block
specif
direct
assembl
endtoend
headtotail
sidetosid
expos
appropri
bath
condit
acid
ph
tmv
rod
tend
align
headtotail
form
long
wire
due
hydrophob
interact
dipolar
end
tmv
rod
tmv
wire
stabil
condens
form
bundl
assist
anilin
situ
polymer
polyanilin
addit
incorpor
dna
hybrid
progress
also
made
toward
greater
control
specif
order
viral
particl
assembl
endtoend
accomplish
end
phage
function
differ
dna
oligonucleotid
manner
introduct
appropri
hybrid
oligonucleotid
led
assembl
order
phage
trimer
figur
although
work
investig
control
sequenc
phage
label
differ
fluoresc
dye
futur
extend
format
heterofunct
multiphag
structur
distinct
moieti
impart
complex
function
high
aspect
ratio
structur
form
tmv
phage
fd
also
long
use
produc
studi
liquid
crystallin
arrang
may
find
applic
nextgener
electron
display
yield
liquid
crystallin
assembl
insolut
mix
protocol
develop
drive
align
spatial
organ
proteinac
build
block
classic
approach
make
use
concentr
gradient
nemat
liquid
crystallin
phase
gener
critic
concentr
onset
order
explain
onsag
theori
isotropicnemat
phase
transit
state
competit
translat
orient
entropi
lead
higher
densiti
favor
nemat
phase
order
confer
greater
translat
entropi
filament
virus
abl
form
mesophas
exhibit
rodshap
liquid
crystal
materi
nemat
cholester
smectic
smectic
c
exist
interchang
exampl
phagebas
liquid
crystal
present
nemat
phase
low
concentr
concentr
increas
cholester
liquid
crystallin
phase
observ
final
high
concentr
system
exhibit
smectic
liquid
crystallin
phase
furthermor
base
anisotrop
natur
filament
virus
extern
stimuli
electr
magnet
field
appli
tune
order
therefor
allow
align
whole
sampl
order
also
achiev
liquidliquid
liquidsolid
interfac
instanc
oilwat
interfac
perfluorodecalin
water
explor
found
tmv
rod
align
parallel
interfac
low
concentr
align
normal
interfac
high
concentr
could
attribut
compromis
maxim
interfaci
interact
minim
electrostat
repuls
rod
parallel
align
tmv
also
achiev
assembl
interfac
buffer
lipid
monolay
support
submerg
hydrophob
substrat
inclus
ca
ion
help
screen
coulomb
repuls
particl
anoth
possibl
format
assembl
high
aspect
ratio
virus
mixtur
sphere
increas
free
energi
interfac
favor
assembl
uniform
structur
observ
studi
isotrop
nemat
lamellar
crystallin
phase
obta
ine
modul
concentr
tmv
concentr
bsa
peg
sphere
ionic
strength
addit
dival
metal
cation
also
shown
induc
format
order
aggreg
tmv
precipit
tmv
nemat
liquid
crystal
properti
form
addit
ion
cd
zn
cu
ni
effect
extend
alkalin
earth
metal
ca
mg
furthermor
highli
order
optic
birefring
film
form
aggreg
dri
glass
surfac
hypothes
tmv
contain
lowaffin
metal
bind
site
induc
crosslink
presenc
metal
ion
benefici
liquid
crystal
applic
behavior
pose
import
consider
format
welldispers
biominer
tmv
desir
format
hybrid
materi
exampl
achiev
condit
dens
copper
deposit
without
aggreg
tmv
templat
challeng
nevertheless
excit
new
properti
may
possibl
result
particl
assembl
assembl
tmv
presenc
ba
particular
interest
instead
liquid
crystallin
order
found
dival
metal
ion
studi
tmv
crystal
hexagon
superlattic
may
interest
electron
properti
addit
insolut
techniqu
electrospin
wet
spin
dip
coat
appli
gener
longrang
order
filament
virusbas
film
exampl
vari
chiral
liquid
crystallin
phage
film
obtain
use
dip
coat
method
care
adjust
phage
concentr
pull
speed
bath
condit
surfac
chemistri
surfac
chemistri
solid
support
supramolecular
film
nemat
orthogon
twist
cholester
helic
ribbon
smectic
helicolid
nanofila
could
produc
array
exhibit
uniqu
optic
photon
properti
film
show
iridesc
illumin
potenti
applic
reflector
display
anoth
potenti
area
applic
lie
colorimetr
sens
exampl
matric
form
use
dip
coat
display
bind
peptid
explos
tnt
show
signific
enough
structur
chang
presenc
tnt
vapor
level
ppb
could
select
distinguish
figur
anoth
area
interest
use
viral
build
block
pattern
surfac
accomplish
use
varieti
strategi
includ
conjug
chemistri
electrostat
interact
pattern
virusbas
nanobuild
block
also
demonstr
use
photolithograph
microcontact
print
strategi
hard
elastomer
pattern
ink
virion
stamp
onto
function
surfac
prime
interact
virusbas
nanoparticl
toward
freestand
film
recent
demonstr
develop
detach
mesopor
film
use
combin
nanospher
lithographi
electrodeposit
form
nanopattern
conduct
viruspolym
array
figur
accomplish
hexagon
closepack
array
polystyren
ps
latex
microspher
creat
use
colloid
nanospher
lithographi
yield
mesopor
architectur
conduct
poli
acid
film
electrochem
polymer
interstiti
void
ps
bead
cyclic
voltammetri
follow
ps
templat
remov
cpmv
particl
deposit
atop
conduct
polym
film
electrostat
adsorpt
hydrogen
bond
result
janu
polymerviru
film
found
robust
stabl
allow
electrochem
delamin
substrat
method
vnp
immobil
onto
surfac
util
dna
hybrid
power
techniqu
proven
effect
guid
assembl
materi
space
dna
hybrid
facilit
control
revers
assembl
adjust
sequenc
specif
temperatur
chemic
cue
eg
access
free
nucleotid
tmv
build
block
one
exampl
nucleic
acid
hybrid
appli
program
materi
tmv
underw
mild
disassembl
protocol
expos
end
genom
could
use
code
guid
assembl
vertic
tmv
array
either
directli
correspond
complementari
oligonucleotid
display
surfac
interven
dna
linker
sequenc
specif
tmv
surfac
altern
nucleic
acidbas
method
rna
templat
contain
tmv
oa
pattern
onto
surfac
give
cue
situ
format
tmv
array
surfac
purifi
tmv
coat
protein
ad
icosahedron
also
make
excel
build
block
selfprogram
assembl
crystallin
array
lattic
twodimension
viru
array
cpmv
form
dropanddri
method
mica
substrat
pack
symmetri
control
modul
peg
surfact
concentr
organ
rhombic
hexagon
close
pack
structur
form
attribut
steric
requir
well
charg
distribut
around
capsid
surfac
anoth
approach
util
interfaci
adsorpt
viral
particl
cation
lipid
monolay
form
surfac
aqueou
solut
base
studi
cpmv
tymv
vari
array
architectur
rectangular
hexagon
rhombic
lattic
achiev
use
method
crystal
standard
techniqu
appli
deplet
condens
peg
common
condens
agent
use
induct
viru
crystal
bulk
toward
program
binari
materi
photon
crystal
organ
compact
structur
phage
gold
nanoparticl
dna
interconnector
report
binari
lattic
shown
form
natl
lattic
structur
contain
interpenetr
organ
inorgan
diamond
lattic
assembl
virus
also
mediat
electrostat
selfassembl
organ
particl
crystallin
lattic
use
method
demonstr
introduct
dendron
dendrim
recent
binari
ab
nanoparticl
superlattic
achiev
use
icosahedr
ccmv
either
gold
nanoparticl
avidin
patchi
symmetr
charg
distribut
viru
capsid
surfac
enabl
format
binari
cubic
structur
author
also
recent
extend
concept
nonvir
protein
cage
ferritin
yield
photoact
biohybrid
crystal
phthalocyanin
dye
specif
facecent
cubic
crystal
micron
size
obtain
phthalocyanin
maintain
nativ
properti
suggest
materi
could
find
applic
photodynam
therapi
water
treatment
diagnost
array
oxid
organ
synthesi
programm
viral
scaffold
combin
propens
selfassembl
hierarch
architectur
led
applic
toward
devic
batteri
electrod
digit
memori
devic
energi
storag
devic
discuss
illustr
earlier
section
virus
offer
framework
ligand
peptid
display
result
facilit
precis
deposit
inorgan
organ
materi
metal
metal
oxid
semiconductor
graphen
carbon
nanotub
energyrelev
materi
achiev
digit
memori
viru
hybrid
creat
exhibit
conduct
switch
behavior
one
method
fabric
devic
involv
decor
tmv
pt
nanoparticl
use
form
composit
layer
pva
matrix
sandwich
two
electrod
result
charg
trap
nanoparticl
devic
exhibit
bistabl
low
conduct
high
conduct
state
observ
applic
revers
bia
v
forward
bia
v
respect
figur
similar
manner
cpmv
decor
semiconduct
quantum
dot
also
demonstr
bistabl
onoff
electr
behavior
addit
system
shown
process
revers
could
undergo
repeat
cycl
read
write
although
maximum
limit
found
around
cycl
suggest
need
refin
investig
establish
use
biomateri
hybrid
system
memori
storag
motiv
explor
futur
possibl
earli
work
scaffold
form
cpmv
investig
posit
redoxact
speci
ferrocen
viologen
viral
templat
multival
redoxact
nanoparticl
exhibit
simultan
multielectron
transfer
indic
multipl
redox
center
independ
behav
essenti
noninteract
redox
unit
materi
may
envis
multielectron
reservoir
nanoscal
electron
transfer
mediat
redox
catalysi
amperometr
biosensor
anoth
electr
applic
virus
involv
util
batteri
electrod
research
perform
creation
cathod
anod
base
well
tmv
templat
use
selfassembl
virus
fabric
high
perform
small
batteri
electrod
made
possibl
earli
studi
util
grow
cobalt
oxid
nanowir
serv
activ
anod
materi
demonstr
viru
network
format
versatil
method
could
appli
format
electrod
rigid
flexibl
substrat
full
electrochem
function
greater
capac
addit
hybrid
nanowir
ni
nanoparticl
found
enhanc
effici
cycl
life
instead
use
biotempl
manganes
oxid
serv
cathod
lithiumoxygen
batteri
improv
capac
porou
network
form
viru
also
observ
hand
tmv
electrod
develop
util
abil
assembl
vertic
substrat
form
nanoforest
high
surfac
area
room
accommod
volum
expans
engin
tmv
anod
involv
sn
nanoparticl
deposit
nicoat
tmv
coat
carbon
way
sn
aggreg
usual
occur
expand
perform
sodium
ion
batteri
suppress
altern
tmvbase
cathod
design
integr
lithium
ion
batteri
form
coat
tmvtemplat
ni
nanorod
ti
lifepo
carbon
asid
excel
electrochem
perform
tmv
electrod
exhibit
high
mechan
electron
integr
addit
electrod
exampl
note
one
util
iridium
oxid
anod
materi
iro
excit
electrochrom
materi
experi
color
chang
electr
potenti
applic
use
properti
paperlik
display
devic
chemic
attach
gold
nanoparticl
miner
iro
iro
au
hybrid
nanowir
form
enhanc
electron
mobil
porou
electrod
made
nanowir
exhibit
remark
switch
time
ms
oxidationcolor
ms
reductionbleach
promis
applic
requir
fast
electrochrom
energi
materi
engin
viral
scaffold
energi
storag
gener
devic
includ
graphen
sheet
conduct
framework
aupt
coreshel
catalyt
nanowir
first
case
use
stabil
graphen
sheet
aqueou
media
stabil
prevent
spontan
aggreg
individu
graphen
sheet
also
serv
viral
templat
facilit
nucleat
bismuth
oxyfluorid
convers
reaction
cathod
materi
form
graphenebismuth
oxyfluorid
nanocomposit
could
use
conduct
framework
energi
storag
improv
electron
transfer
kinet
case
catalyt
nanowir
mention
use
templat
miner
au
follow
pt
design
fuel
cell
applic
au
core
cocatalyst
oxid
remov
carbon
monoxid
pt
nanowir
could
use
oxid
ethanol
less
vulner
carbonac
speci
form
strategi
demonstr
excel
catalyt
activ
addit
advantag
simpl
scaleup
synthesi
greater
durabl
pt
catalyst
lower
cost
due
presenc
reduc
dead
volum
au
core
final
exampl
energi
gener
potenti
phage
liquid
crystal
form
phage
shown
exhibit
piezoelectr
properti
glutam
acid
residu
introduc
nterminu
pviii
coat
protein
order
creat
greater
net
dipol
moment
direct
nterminu
posit
charg
cterminu
result
enhanc
effect
piezoelectr
coeffici
phage
film
selfassembl
phage
monolay
nemat
structur
phage
multilay
smectic
structur
demonstr
piezoelectr
behavior
respons
increas
accord
increas
film
thick
satur
occur
around
thick
nm
investig
demonstr
easili
fabric
multilay
phage
film
spontan
order
dropcast
energi
output
mechan
pressur
film
suffici
turn
liquid
crystal
display
overal
phagebas
technolog
present
opportun
environment
friendli
energi
gener
light
harvest
system
found
photosynthesi
machineri
plant
enabl
convers
light
energi
chromophor
transport
energi
use
reson
energi
transfer
fret
wherebi
electron
excit
upon
photon
absorpt
one
chromophor
transfer
energi
anoth
chromophor
undergo
relax
photon
emiss
excit
energi
get
transfer
cascad
donor
acceptor
energi
level
absorpt
emiss
match
photosynthesi
system
plant
contain
precis
space
array
chromophor
facilit
light
harvest
convers
energi
one
f
natur
sophist
energi
convers
complex
synthet
light
harvest
system
great
interest
basic
energi
scienc
technolog
develop
implement
solar
panel
photovolta
devic
like
photosynthet
machineri
viral
capsid
provid
mean
precis
posit
chromophor
spatial
control
subnanomet
level
recogn
engin
design
space
exampl
publish
use
selfassembl
tmv
scaffold
brief
tmv
coat
protein
coval
label
either
donor
acceptor
fret
pair
assembl
disk
rod
structur
control
ratio
donor
acceptor
assembl
chromophor
could
posit
close
proxim
tunabl
distanc
way
achiev
effici
fret
similarli
display
zinc
porphyrin
also
shown
promis
light
harvest
antenna
fret
observ
porphyrin
serv
donor
acceptor
exciton
migrat
along
viru
recent
studi
reveal
groundbreak
work
enhanc
effici
energi
transport
light
harvest
devic
first
time
experiment
evid
found
demonstr
regim
quantum
coher
classic
incoher
mechan
interact
enhanc
exciton
transfer
effici
compar
found
classic
fret
genet
engin
util
regul
distanc
chromophor
bind
site
either
around
classic
clone
clone
distanc
short
enough
increas
coupl
strength
short
experi
complet
quench
fluoresc
measur
virion
modifi
rang
donortoacceptor
ratio
chromophor
demonstr
superior
behavior
clone
figur
addit
enhanc
exciton
diffus
length
excit
outcom
demonstr
enhanc
exciton
transport
previous
theoriz
anoth
part
light
harvest
process
filament
virus
also
employ
electron
harvest
nanowirebas
photoanod
due
abil
form
porou
network
high
surfac
area
previou
work
investig
implement
dyesensit
solar
cell
dssc
design
dssc
involv
presenc
dye
photosensit
light
absorpt
excit
transfer
energi
conduct
band
tio
photoanod
diffus
current
collector
fluorinedop
tin
oxid
use
sacrifici
templat
photoanod
format
shown
highli
interconnect
porou
tio
structur
could
achiev
greater
charg
transport
effici
strategi
creat
porou
tio
network
includ
use
electrostat
interact
complex
tio
nanoparticl
virus
layerbylay
phage
deposit
tio
nucleat
crosslink
phage
glutaraldehyd
form
hydrogen
tio
nucleat
remov
sacrifici
viral
scaffold
photoanod
found
possess
improv
electron
diffusio
n
properti
addit
incorpor
gold
nanoparticl
dye
molecul
found
also
experi
greater
light
absorpt
local
surfac
plasmon
reson
therefor
improv
light
harvest
anoth
step
toward
improv
dssc
photovolta
stabil
swnt
noncoval
bind
biominer
tio
use
success
incorpor
swnt
photoanod
due
high
electron
mobil
swnt
high
power
convers
observ
strategi
anoth
exampl
photovolta
cell
involv
miner
perovskit
nanocryst
uniqu
catalyt
electr
magnet
properti
particular
use
templat
strontium
titan
sto
bismuth
ferrit
bfo
miner
studi
present
first
report
photovolta
properti
bfo
nanoparticl
show
effect
absorpt
visibl
light
solar
power
convers
effici
hand
sto
nanowir
exhibit
photocatalyt
water
reduct
properti
could
use
effici
hydrogen
product
uv
visibl
light
addit
research
area
investig
improv
perform
sto
nanowir
visibl
light
wherea
dyesensit
requir
previou
studi
new
fabric
method
develop
util
ammonia
ga
treatment
tune
optic
absorpt
sto
nanowir
success
manufactur
visiblelight
activ
photocatalyst
light
convers
also
explor
tmv
studi
tmv
arrang
vertic
goldcoat
indium
tin
oxid
ito
surfac
particl
coat
nickel
ito
follow
cuo
ito
serv
current
collector
cuo
serv
photocathod
high
enough
tmv
densiti
film
found
form
antireflect
surfac
due
high
surfac
area
surfac
rough
benefici
greater
photoelectrochem
cell
effici
variou
cuo
thick
investig
thick
nm
found
produc
one
highest
photocurr
densiti
report
cuo
system
size
overal
properti
virustempl
surfac
bring
much
promis
futur
photoelectrochem
applic
catalyt
water
convers
nanostructur
alreadi
led
breakthrough
optic
nanophoton
well
biotechnolog
biomedicin
nanometers
nobl
metal
particl
de
brogli
wavelength
valenc
electron
order
magnitud
size
particl
result
quantum
size
effect
may
observ
characterist
plasmon
reson
band
lead
extraordinari
metal
enhanc
effect
aris
due
oscil
valenc
electron
collect
oscil
frequenc
know
nanostructur
design
organ
plasmon
band
fine
tune
applic
bodi
plasmon
rang
nir
imag
window
light
penetr
sever
centimet
tissu
desir
substanti
absorpt
scatter
properti
plasmon
nanostructur
use
contrast
agent
optic
imag
optic
coher
tomographi
photoacoust
imag
demonstr
potenti
applic
plasmon
sens
use
viral
plasmon
achiev
use
phage
load
gold
nanocub
ser
altern
plasmon
nanostructur
also
applic
therapeut
context
due
transform
absorb
light
heat
could
appli
thermal
ablat
tumor
control
releas
drug
use
theranost
reagent
diagnost
imag
therapeut
function
merg
present
anoth
option
beyond
healthcar
note
plasmon
also
appli
mani
disciplin
includ
nonlinear
plasmon
electron
transport
local
heat
biosensor
quantum
optic
metamateri
virusbas
plasmon
metamateri
synthesi
first
demonstr
bmv
shell
assembl
around
gold
nanoparticl
core
crystal
form
particl
exhibit
optic
transmiss
spectrum
indic
multipolar
plasmon
coupl
adjac
gold
core
recent
phage
function
intern
gold
nanoparticl
extern
fluorophor
interven
distanc
control
use
oligonucleotid
hairpin
figur
enhanc
fluoresc
intens
correspond
decreas
lifetim
observ
result
correl
well
expect
effect
separ
plasmon
gain
materi
revers
configur
intern
fluorophor
gold
nanoparticl
antenna
fluoresc
enhanc
also
observ
found
function
nanoparticl
size
separ
plasmon
gain
materi
interest
electromagnet
effect
gener
wellstructur
order
plasmon
materi
properti
virus
provid
recent
exampl
explor
potenti
involv
precis
placement
plasmon
gold
nanoparticl
defin
space
symmetri
use
cysteinefunction
cpmv
cpmv
engin
allow
gold
place
vertic
around
capsid
result
plasmon
nanoclust
demonstr
reson
visibl
wavelength
due
interact
neighbor
gold
nanoparticl
finiteel
simul
suggest
structur
like
give
rise
enhanc
local
electromagnet
field
nearfield
coupl
overal
virus
exploit
develop
dizzi
array
applic
fall
broad
scope
medicin
biotechnolog
energi
area
medicin
vaccin
gene
deliveri
around
applic
virus
area
drug
deliveri
tissu
engin
recent
conceptu
develop
mani
diseas
still
much
tackl
improv
effect
diagnosi
treatment
one
challeng
great
interest
transit
new
virusbas
nanomateri
clinic
attain
exquisit
control
abil
regul
immun
respons
clearanc
behavior
specif
applic
immunogen
proteinac
coat
viral
particl
advantag
immunotherapi
undesir
particl
use
nanocarri
imag
drug
deliveri
shown
elimin
particl
antibodi
tune
pegyl
altern
coat
serum
albumin
reduc
immun
respons
confer
stealth
properti
repeat
administr
virusbas
nanomateri
applic
diagnost
therapeut
becom
achiev
biotechnolog
mani
advanc
field
virusbas
devic
sens
diagnost
catalysi
agricultur
pharmaceut
product
highlight
achiev
phage
display
becom
familiar
techniqu
armor
rna
molecular
diagnost
control
commerci
avail
scaledup
manufactur
pharmaceut
plant
shown
cheap
effect
altern
excit
develop
underway
includ
effici
catalysi
hydrogen
clean
fuel
product
use
plant
virus
combat
diseas
plant
long
widespread
adopt
newer
technolog
follow
final
abundantli
clear
virus
present
great
opportun
manufactur
energyrelev
materi
along
abil
selfassembl
order
array
virus
offer
possibl
precis
posit
nanoscal
distinct
advantag
reveal
novel
materi
properti
enhanc
plasmon
behavior
recent
breakthrough
enhanc
light
harvest
effici
exemplifi
advantag
wellord
viru
scaffold
deeper
understand
viru
structur
assembl
combin
new
approach
synthet
virolog
yield
ever
complex
formul
enabl
new
function
remain
excit
viruschemistri
interfac
simplifi
illustr
show
common
method
interior
exterior
viru
modif
alter
composit
protein
capsid
genet
engin
use
avail
expos
residu
bioconjug
chemistri
perform
pore
structur
small
cargo
infus
capsid
retain
reduc
pore
size
electrostat
interact
interact
metal
precursor
capsid
use
select
direct
miner
interior
exterior
surfac
take
advantag
selfassembl
viral
scaffold
cargo
introduc
assembl
encapsul
brightfield
imag
reveal
support
msc
adhes
scaffold
pore
column
c
immunofluoresc
stain
endotheli
hematoxylin
eosin
h
e
stain
implant
neg
control
wildtyp
phage
virusactiv
matrix
vam
posit
control
rgdphage
vegf
scaffold
respect
well
quantit
analysi
fluoresc
gfpg
infiltr
tissu
measur
n
benthamiana
leav
agrobacterium
infiltr
top
leav
also
imag
uv
light
bottom
label
figur
indic
plasmid
use
transform
result
indic
superior
express
protein
trbo
vector
compar
previou
express
vector
even
enhanc
previou
iter
promoterdriven
tmvbase
express
vector
includ
express
tmv
gene
addit
gene
insert
plasmid
express
rnasilenc
suppressor
protein
pjl
trbog
gfpexpress
trbo
vector
gfp
plasmid
gfp
express
control
promot
reproduc
permiss
ref
topograph
tap
mode
afm
imag
illustr
initi
format
closepack
ps
microspher
partial
remov
ps
sphere
b
pattern
poli
acid
electropolymer
c
nonpattern
film
e
optic
microscop
imag
overlay
cpmv
pattern
polym
electrostat
delamin
film
creat
freestand
film
inset
show
topograph
afm
imag
indic
point
film
reproduc
permiss
ref
